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ABSTRACT 
 
 RNA-mediated silencing is a conserved mechanism by which the cleaving of 
double stranded RNA (dsRNA) causes the degradation of homologous mRNA within the 
cell.  Ribonuclease activity within the RNAi mechanism has been thoroughly described in 
model organisms such as Caenorhabditis elegans.  However, RNAi is still largely a 
mystery in Apicomplexan parasites.  Our group previously has reported that specific gene 
silencing via the introduction of dsRNA in Toxoplasma gondii can be achieved.   
Furthermore, a key protein has been characterized, namely the Argonaute protein.  In this 
study, through the use of bioinformatic tools, several putative proteins that may act upon 
the RNAi mechanism have been identified.  Furthermore in vitro dsRNA-directed 
ribonuclease activity and dsRNA-specific ribonuclease activity in Toxoplasma gondii 
lysates were assessed.  Lastly, using a His construct, the Argonaute protein in T. gondii 
was successfully isolated from inclusion bodies and characterized in terms of its 
interaction with RNA species.  This study demonstrates the presence of an RNAi-like 
mechanism in T. gondii and can aid in determining future drug targets in this parasite. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Toxoplasma gondii 
Toxoplasma gondii is an obligate intracellular parasite belonging to the phylum 
Apicomplexa.  T. gondii as a parasite was first described in 1908 by Nicolle and 
Manceaux while working in North Africa on rodents and by Splendore working on 
rabbits in Brazil (Nicolle, 1908).  The name of the parasite was adopted due to its bow-
like crescent shape (toxon = bow, plasma = form) and the rodent it was isolated from 
Ctenodactylus gundii (Black and Boothroyd, 2000). 
It has been suggested that nearly 30% of North Americans are carriers of T. gondii.  
However, in most of the cases, infection is asymptomatic and individuals lead a normal 
lifestyle.  In immuno-compromised individuals, severe toxoplasmosis can arise due to the 
lack of a functional immune system, which often results in brain and eye damage.   T. 
gondii infections in pregnant women can also affect the fetus tremendously, resulting in 
spontaneous abortions, fetal death and severe birth defects (Luft and Remington, 1992).  
Like many other intracellular parasites, upon cell invasion, it was shown that T. gondii 
prevents the host cell from undergoing apoptosis by inactivating the caspase cascade 
(Kim et al., 2006). 
The life cycle of T. gondii is made up of two distinct replication cycles, namely 
the sexual and the asexual cycles.  The sexual cycle of T. gondii takes place in felines, the 
definitive host of these parasites.  Cats usually become infected upon ingestion of prey 
such as rats or birds that are carriers of the parasite. Once the encysted parasites reach the 
small intestine of cats, they are released and infection usually starts with the epithelial 
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cells.  Due to the slow immune response in cats, the parasites are able to start dividing 
and are able to produce millions of oocytes, which are then released in the environment in 
the feces of the animal.  Sporulation then occurs within 1 to 5 days after excretion and 
these oocytes remain infectious for months regardless of the severity of the climate 
(Dubey, 1994). 
The asexual cycle may take place in a plethora of species, including land and sea 
mammals, as well as humans (Mikaelian et al., 2000).  Infections in these species usually 
occurs by direct ingestion of cat feces or poorly cooked meat containing the viable cysts, 
after which the tachyzoites distribute themselves in the body of the host until an immune 
response is reached.  This immune response causes the fast replicating tachyzoites to shift 
to the bradyzoite stage, in which the parasite continues the slow replication process 
through the remainder of the host’s life (Black and Boothroyd, 2000). 
During the infectious stages T. gondii has the ability to convert between a rapidly 
replicating form named tachyzoite and a slower growing form termed bradyzoite.  The 
advantages of this stage inter-conversion process is that in the bradyzoite stage the 
parasite requires less energy to survive and it is also able to escape the host’s immune 
response while the tachyzoites are readily recognized and eliminated (Freyre, 1995).  
Recurring acute infections are likely the result of the inability of the host’s immune 
response to detect the bradyzoite cysts (Gross et al., 1996).  The current available 
treatment for this condition is in the form of a antimicrobial cocktail aimed at inhibiting 
the function of dihydropteroate synthetase and dyhydrofolate reductase.  This 
chemotherapy is fairly effective in the acute stages of the infection however the treatment 
described may cause severe side effects and toxicity in the patients and are inefficient 
against bradyzoites (Black and Boothroyd, 2000). 
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1.1.2 Parasite strains and culture conditions 
Toxoplasma gondii can be safely cultured in vitro in a plethora of cell types, although 
Human Foreskin Fibroblasts (HFF) is generally the preferred cell line.  This is due to the 
fact that HFF cells allow for a greater number of replication cycles due to their 
morphology and surface area producing a higher parasitic yield with reduced debris 
derived from cell lysis.  Other advantages for the utilization of HFF cells is that they are 
very robust by comparison with other cell lines, allowing for culturing and maintenance 
of these monolayers for an extended period of time before infection occurs.  In addition, 
HFF cells are resistant to many known metabolic inhibitors and facilitate drug selection 
of parasites.  Some disadvantages are their slow growth rate at high passages and a 
limited lifespan with respect to replication (Roos et al., 1994). 
There are several T. gondii strains that are commonly used in the laboratory setting 
that fall under the category of Type I, II or III based on their virulence. Type I parasites 
are the most virulent due to what is thought to be their higher rate of reinvasion rather 
than faster replication (Saeij et al., 2005).  Some common parasitic strains include RH, 
VEG, ME49 and a sub-clone of the latter termed PLK.  The RH strain is characterized by 
its ability to replicate quickly and it has been described as highly virulent.  It is one of the 
most commonly cultured strains and is generally used to characterize drug resistance and 
virulence (Roos et al., 1994).  This particular strain does not have the ability to actively 
convert to the bradyzoite stage, and it also lacks the ability to undergo sexual 
reproduction in felines (Freyre, 1995).  The trend of virulence seems to be inversely 
proportional to the ability to produce cysts.  The ME49 strain is less virulent than the RH 
strain and it has the capability of converting into bradyzoites under stress with high 
efficiency, making it an ideal candidate when studying differentiation of the parasite from 
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tachyzoites to bradyzoite.  The PLK sub-clone of ME49 has slower replication rates and 
is commonly used to study the life cycle due to the ability to produce bradyzoite cysts and 
being able to undergo full sexual reproduction (Boothroyd et al., 1997). 
 
1.1.3 T. gondii as an Apicomplexan model 
A large number of pathogenic species belong to the phylum Apicomplexa, and the 
current drug therapies available are at risk due to emerging drug resistance in these 
parasites.  Some Apicomplexan parasites are also very difficult to maintain in the 
laboratory setting such as the malaria causing parasite Plasmodium falciparum (Sibley, 
2003).  This problem has not been encountered in T. gondii as it can be safely maintained 
using standard cell culture techniques in host cells that are rather robust and easily 
obtained.  Another attractive feature of T. gondii in this regard is that it is susceptible to 
genetic manipulation, essentially making any gene within it a feasible study target.  
Molecular transformation through transient and stable transfection has been achieved and 
has become a very important tool in determining gene function in T. gondii (Kim and 
Weiss, 2004).  Various genetic tools are now used to study gene expression in T. gondii, 
such as the tetracycline repressor system described by Meissner, as well as insertional 
mutagenesis (Donald and Roos, 1995; Nakaar et al., 2000; Meissner et al., 2001). 
With recent advancements in bioinformatics, the genomic information of T. gondii is 
readily available via the genomic database ToxoDB (http://www.ToxoDB.org, Kissinger, 
et al., 2003).  This may lead to not only a better understanding of this particular 
Apicomplexan parasite, but may also uncover new applications for future drug targets.  
Apicomplexans generally maintain the same orthologs within their enzyme arsenal, and 
the sequenced genome combined with ease of culturing and genetic manipulation, 
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Toxoplasma gondii emerges as the ideal Apicomplexan model.  It should be noted 
however that greater dissimilarities have been witnessed between T. gondii and 
evolutionary distant Cryptosporidium. Therefore, T. gondii may not be a suitable model 
for such parasites however it still remains the ideal model in studying genetic functions 
for Apicomplexans such as P. falciparum (Nene et al., 2000; Striepen and Kissinger, 
2004). 
 
1.2 RNA Interference 
1.2.1 RNA interference phenomenon 
RNA-mediated silencing is a conserved mechanism by which the cleaving of double 
stranded RNA (dsRNA) causes the degradation of homologous messenger RNA (mRNA) 
within the cell.  Initially, the phenomenon of RNAi was observed in plants, and it was 
characterized as a defence mechanism against viral infections, by which double stranded 
RNA of viral origin, is disposed of in the cells.  As more experimental attention was 
devoted to this mechanism, it was noticed that the expression of genes may be reduced in 
organisms such as Caenorhabditis elegans and Drosophila melanogaster upon the 
introduction of dsRNA with complementary sequences to endogenous mRNA molecules 
within those species.  Remarkably, RNAi has become one of the leading techniques in 
studying gene function through knockdown and shows great promise as a tool in the 
therapeutic development against a plethora of infectious diseases (Novina and Sharp, 
2004). 
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1.2.2 RNAi Mechanism 
Extensive work has been done to determine the mechanism by which RNA 
interference transcends and it was determined that it involves an initiator step and an 
effector step.  In the initiation step, the dsRNA introduced is cleaved into nucleotides 
segments varying from 21 to 23 base pairs in length by a member of the RNase III family 
of dsRNA specific RNAse III endonuclease, Dicer.  Dicer recognizes the long dsRNA 
substrate through its double stranded RNA binding domain, producing siRNAs with a 5’ 
phosphate and 2 base pair overhang in the 3’ direction, which are believed to facilitate the 
target RNA cleavage (Elbashir et al., 2001).  Dicer has also been shown to recognize 
hairpin RNA structures, preparing them into micro RNAs (miRNAs) causing translational 
suppression, with the miRNAs produced varying in complementarity to the target mRNA 
on a species-dependent manner.  Some reports indicate that this process is an ATP 
dependant step (Zamore et. al., 2000; Nykanen et al., 2001) however in humans this 
process is performed without a requirement for ATP (Zhang et al., 2003). 
The effector step begins with the recruitment of a multi protein complex termed the 
RNA-induced silencing complex (RISC) which acts mainly through the Argonaute 
protein.  Binding of Argonaute to the siRNAs takes place mainly through its PIWI-
Argonaute-Zwille (PAZ) domain, while the PIWI portion of the protein acts as the slicer.  
Upon binding, Argonaute specifically cleaves the passenger strand or the sense strand on 
the siRNA structure which is determined thermodynamically according which strand that 
has the lowest thermodynamic stability in its 5’ end (Schwarz et al., 2003).  The strand 
that is still associated with the RISC complex is termed the guide strand and it aids in the 
target mRNA recognition and binding.  The binding between the guide strand and the 
RISC complex is rather robust by comparison to the interaction between the target mRNA 
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and the siRNA.  This interaction facilitates the cleavage of the target mRNA, which is 
achieved in an ATP dependent manner followed by the ejection of the complementary 
mRNA molecule.  The sliced mRNA fragments are discarded and completely degraded 
within the cytoplasm (Nykanen et al., 2001).  In organisms such as C. elegans, siRNA 
propagation takes place in which RNA dependent RNA polymerase proteins recognize 
siRNA-mRNA duplexes and trigger the synthesis of a new dsRNA strand, which in turn 
is prepared into siRNAs by Dicer and signal amplification is achieved (Carmell and 
Hannon, 2004).  The RNAi mechanism is illustrated in Figure 1.1. 
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Figure 1.1  The mechanism of RNA interference.  The mechanism is initiated by the 
presence of long dsRNA, which is in turn processed by Dicer.  This produces siRNAs 21-
23 base pairs in length.  Next, the Argonaute protein associates with the siRNAs produced 
and together they form a scaffold facilitating RISC formation.  Upon RISC formation, the 
passenger strand is expelled, allowing for mRNA binding, triggering the slicing activity 
of Argonaute within RISC.  The figure was adapted from Matzke and Matzke 2004. 
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1.2.3 Key features of RNAi and its components 
Whether it is labelled post-transcriptional gene silencing (plants), RNA interference 
(mammals) or quelling (fungi), some common key features are recognized in all these 
mechanisms.  One of the key features within the mentioned mechanisms is the ability of 
dsRNA to induce the particular response in fungi, plants and animals alike.  Due to this, 
dsRNA is generally regarded as an inducer of RNAi.  The second feature that is present in 
these mechanisms is the degradation of a target RNA species based on the 
complementarity to the inducer, and lastly, a third specific feature is the degradation of 
target RNA by a machinery comprised of proteins that maintain high similarity in 
structure and function within these organisms. 
Genetic screens for RNAi-deficient mutants in model organisms such as A. thaliana, 
Chlamydomonas reinhardtii, Neurospora crassa and C. elegans has expanded the 
understanding of the RNAi pathway as a whole, revealing the most important players in 
this mechanism.  The initiators were found to be RNase III family proteins such as Dicer, 
while the effectors were determined to be proteins from the Argonaute-PIWI family.  
Lastly, the amplifiers of RNAi have been identified to be RNA-Dependent RNA 
polymerases (Agrawal et al., 2003).  
 
1.2.3.1 RNase III protein Family and Dicer 
A key feature of RNase III family proteins is their ability to specifically bind and 
cleave dsRNA.  The members of this particular protein family all carry a signature 
ribonuclease domain, often referred to as the RNase III domain.  Another characteristic 
feature of these proteins is the production of dsRNA with a specific two base pair 
overhang in the 3’ direction and a 5’ phosphate group (Gan et al., 2006). 
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There are three main classes of RNase III proteins (Figure 1.2).  Class 1 RNase III 
enzymes are of bacterial origin and are the smallest members of the RNase III protein 
family.  These enzymes generally contain two domains, namely the ribonuclease domain 
(RNase III) and a double stranded RNA binding domain (dsRBD) connected through 
flexible linkers.  Dimerization of Class 1 RNase III proteins is common and this 
interaction is thought to occur through the ribonuclease domains (Nagel et al., 2000).  
Through mutagenesis, Zhang determined that the active unit of RNase III enzymes is 
actually a ribonuclease domain dimer arranged opposite to one another that work 
independently on the particular 3’ or 5’ end of the dsRNA substrate (Zhang et al., 2004).  
Extensive work in Saccharomyces cerevisae allowed for better understanding of its 
RNase III protein Rnt1, making it one of the best characterized eukaryotic Class 1 RNase 
III enzymes.  The function of Rnt1 has been linked to processing of yeast pre-rRNAs and 
many small nuclear and nucleolar RNAs (MacRae et al., 2007).  Although it has the 
ability to process many substrates in yeast, the common feature of these substrates is the 
specific hairpin structure of the dsRNA it binds containing the consensus sequence 
AGNN, and although it was thought that the adenine and guanine nucleotides participate 
in hydrogen bonding to the enzyme, it was shown that they simply have structural 
implication within the RNA hairpin molecule rather than offering an improved binding 
efficacy to the dsRBD of the protein (Wu et al., 2004; Leulliot et al., 2004).  Through the 
recognition of the consensus sequence, the dsRBD is then able to position the hairpin 
molecule within the active site of the ribonuclease domain at a distance of 13-16 base 
pairs from the loop. 
The second main class of RNase III proteins, Class 2 contains Drosha protein found in 
Drosophila.  Although the structure of this protein has not been yet obtained, it has been 
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postulated that it acts as a monomer rather than the dimeric formation witnessed in Class 
1 RNases.  Drosha contains four well defined domains, namely a proline rich region, a 
dsRBD and two RNase III domains, denoted as RNase IIIa and RNase IIIb.  The working 
hypothesis for the mode of action of Drosha is that the two RNase III domains interact to 
produce the catalytic site.  Drosha is involved mainly in the processing of pre-rRNAs in 
humans and it plays a major role in miRNA maturation (Wu et al., 2000; Lee et al., 
2003).  Drosha normally cleaves pre-miRNA hairpins, which are then further processed 
by Dicer into mature miRNA.  Studies using purified Drosha showed that the accuracy of 
excising pre-miRNA hairpins is lost and more specifically, it acts as a general RNase III 
protein.  Substrate and cleavage specificity however were shown to be coupled to the 
interaction between Drosha and its partner DGCR8 (DiGeorge syndrome critical region 
gene 8).  Such critical evidence moulded current thinking in that DGCR8 is the Drosha 
accessory protein which directs substrate selection and specificity (Han et al., 2006).  
Evidence of the interaction between DGCR8 and Drosha are seen at a structural level due 
to the proline binding WW domain that DGCR8 displays, facilitating the interaction with 
the proline rich N-terminal region of Drosha (Gregory et al., 2004).  A DGCR8 
orthologue is found in C. elegans named Pasha, which in conjunction with Drosha, play a 
significant role in the processing of pre-miRNAs. 
The last class of RNase III enzymes is called Class 3 RNase III or simply Dicer.  The 
Dicer enzymes act on a dsRNA substrate creating siRNAs, or they may act within the 
miRNA pathway in maturing these.  Recently, the Dicer protein structure of Giardia 
intestinalis was resolved through X-ray crystallography and it revealed some important 
structural features that aid in understanding its function. Dicer enzymes possess a very 
 12
distinct helicase domain, namely the DExD/H-box helicase which is generally conserved 
in higher eukaryotes.   
In Giardia, the crystallographic structure revealed that this lower eukaryotic organism 
does not harbour the DExD/H-box helicase, a DUF283 showing a distinct dsRNA binding 
fold, or a dsRBD domain. Its structure did reveal that the domains it possesses fulfil the 
minimum requirement for binding and processing dsRNA.  The domains present are the 
PAZ and the two RNase III domains common in Class 2 and Class 3 RNAse III proteins, 
with the PAZ domain acting in stabilizing and binding end of the incoming dsRNAs to be 
processed.  As seen before, the endonuclease domains of Giardia Dicer behave similarly 
to Class 1 RNase III proteins in the sense that they dimerize internally producing the 
catalytic site (Macrae et al., 2006; Zhang et al., 2004).  Metal ion dependency is often the 
case with proteins interacting with DNA or RNA structures.  Dicer heavily relies on metal 
ions to properly arrange and stabilize the incoming dsRNAs, and it has been shown that 
the nature of the metal ions involved is usually of divalent nature, some examples of 
which are Mg2+, Ni2+ and Co2+ (Macrae et al., 2006).  Products of the Giardia Dicer are 
25-27 base pairs in length, which corresponds to the distance measured from the catalytic 
center produced by the RNase III dimer and the region that binds the 3’ end of the RNA 
on the PAZ domain.  Human dicer however has been shown to produce 21 base pair 
products, indicating that the distance between the PAZ domain and the catalytic domain 
may be slightly shorter than witnessed in Giardia.  
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Figure 1.2 Visual representation of the RNase III family of enzymes.  Bacterial 
RNase III or Class 1 display a small protein containing an RNase III domain coupled with 
a double stranded RNA binding domain (dsRBD) and is thought to be active through 
dimerization.  Class 2 Drosha proteins display their signature polyproline region which 
enables the interaction of Pasha (or DGCR8 protein in humans) along with 2 RNase III 
domains and the dsRBD domain.  Lastly, the most complex RNase III enzymes, the Dicer 
of higher eukaryotes displays the signature DExD helicase domain as well as its distinct 
PAZ domain.  The figure was adapted from MacRae, 2007. 
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1.2.3.2 Argonaute-PIWI protein Family 
In recent years, Argonaute proteins have been subjected to extensive research due 
to their presumed importance in the RNAi mechanism and have since been recognized 
as the central component of the RNA-mediated silencing complexes.  In 2007, the 
crystallographic structure of the Argonaute protein isolated from Pyrococcus furiosus 
revealed two distinct motifs which elucidated the mode of action of this particular 
protein.  The PAZ domain acts as a single stranded nucleic acid binding motif, 
suggested to be actively participating in the binding of the 3’ end of the single 
stranded siRNA, while the PIWI domain has been coined as the catalytic domain of 
this protein, due to its RNase H fold.  The PAZ domain depends heavily on its 
interaction with magnesium ions in order to coordinate its distinct Asp-Asp-Glu 
(DDE) motif, while it has been suggested that the PIWI domain relies on magnesium 
ions to properly arrange its active site of Asp-Asp-His (DDH) motif.  This shows 
close similarities between Argonaute and other RNase H bearing domains (Tolia and 
Joshua-Tor, 2007). 
It should be noted however that while Argonaute proteins are generally regarded 
as the catalytic engine of the RNAi mechanism in regard to mRNA degradation, for 
many Argonaute protein isoforms in several organisms, this does not hold true.  In 
humans, there are 4 Argonaute isoforms, with Argonaute 2 being recognized as the 
only member of the subfamily that is able to exhibit exonuclease activity through its 
DDH catalytic triad.  Although the DDH catalytic motif is present in human 
Argonaute 3, this isoform has been described as catalytically inactive (Liu et al., 
2004).  In C. Elegans, there are 27 Argonaute isoforms that are divided into two 
groups of primary and secondary Argonautes.  The primary Argonaute group is 
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responsible for the initial response through the small dsRNAs derived from the 
cleavage of larger dsRNAs by Dicer and are further processed into siRNA within the 
RISC complex resulting with the degradation of the target mRNA complementary to 
the siRNAs loaded within the complex.  Upon the degradation of the target mRNA, an 
RNA-dependant RNA polymerase generates new dsRNAs which are then utilized by 
the secondary class of Argonaute proteins via an unknown mechanism, resulting in an 
amplified RNAi signal (Steiner et al., 2006). 
Moreover, the family of Argonaute proteins has been further characterized into 
two distinct subfamilies, namely the Argonaute subfamily and the PIWI subfamily 
(Rodriguez et al., 2005) however no functional difference has been yet reported in 
these two subfamilies.  The Argonaute subfamily members have been determined to 
resemble the Arabidopsis Ago1 protein, while the PIWI subfamily members have 
been shown to closely resemble the PIWI protein found in Drosophila (Carmell et al., 
2002).  A graphical representation of the Argonaute protein domains in several 
organisms is provided in Figure 1.3. 
 
 
 
 
 
 
 
 
 
 16
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3  Alignment of various Argonaute proteins.  The key aspect is the presence 
of the PIWI catalytic domain in all of them.  TgAgo (T. gondii Argonaute) is the smallest 
compared to AfPiwi (A. fulgidus PIWI protein), HsAgo2 (human Argonaute 2), AtAgo1 
(A. thaliana Argonaute 1) and TbAgo1 (T. brucei Argonaute 1).  The figure was adapted 
from Al Riyahi et al., 2006. 
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1.2.3.3 RNA-Dependent RNA Polymerases 
RNA-dependent RNA polymerases play a crucial role in the cytoplasmic and 
chromatin RNA silencing pathways in C. elegans, fungi and plants, however their 
presence in insects and mammals has yet to be shown (Baulcombe, 2004).  RdRp was 
initially cloned from the tomato plant, where it is responsible for the production of 
dsRNAs from already present single strand RNA templates (Schiebel et al., 1998).  The 
amplification mechanism for RdRps proposes the recognition and extension of a siRNA-
mRNA duplex forming new dsRNA, which in turn acts as the substrate for Dicer, 
perpetuating the RNA interference response.  Several orthologues are found in A. thaliana 
suggesting the implication of these in several silencing pathways and specificity towards 
different targets might be the case.  Tobacco plants with reduced RdRp1 levels showed an 
increased susceptibility towards infection with the tobacco mosaic virus, while RdRp6 
mutants in A. thaliana are extremely vulnerable towards the cucumber mosaic virus, but 
not to the tobacco mosaic virus (Dalmay et al., 2001; Xie et al., 2001).  Studies with 
Arabidopsis RdRp2 mutants resulted in the lack of endogenous retroelement-derived 
siRNAs, suggesting that perhaps this protein plays a role in the chromatin silencing 
pathway (Xie et al., 2004).  Along the same lines, studies in S. pombe revealed that RdRp 
is crucial for the RNAi mediated heterochromatin assembly (Sugiyama et al., 2005).  In 
C. elegans however, mutant RdRp studies showed that the RNAi response obtained in the 
mutant and the wild type worms are comparable (Sijen et al., 2001). 
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1.2.4 RNA interference in prokaryotes 
 Although prokaryotes do not possess RNAi systems homologous to those found in 
eukaryotic cells, they do possess a system analogous in function to that of eukaryotes 
(Shabalina and Koonin, 2008).  However, key proteins active in viral infections in the 
modern eukaryotic RNAi mechanism do have staggering prokaryotic connections.  For 
example, one of the central proteins in the RNAi mechanism of eukaryotes, Dicer has two 
of its main catalytic domains linked to archaeal and bacterial ancestry.  The catalytic 
domains in question are the RNase III and the Superfamily II RNA helicase domains.  
The helicase domain of eukaryotic Dicer is closely related to archaeal Hef proteins 
(Superfamily II helicases) which aid in DNA replication (Komori et al., 2004).  The 
RNase III domain of Dicer, responsible for the nuclease activity, draws its origins from 
bacteria, where it processes ribosomal RNA (rRNA) and plays an active role in mRNA 
degradation (MacRae et al., 2007).  Another key protein, Argonaute, the slicer protein of 
the RNAi mechanism also seems to have archaeal roots, and although the function of the 
archaeal orthologue is still elusive, it has been associated with chromatin remodelling in 
archaea ((Ma et al., 2005; Aravind et al., 2000). 
 Nonhomologous protein orthologues linked to the RNAi pathway have been 
shown in prokaryotes however it was unclear how these protein orthologues aid in the 
regulation of gene expression of these early organisms until the discovery of small, 
noncoding regulatory RNAs in E. coli.  These noncoding RNAs are similar to eukaryotic 
miRNAs, displaying partial complementarity to the mRNA target, resulting in mRNA 
degradation or inhibition of translation.  Prokaryotes also display a siRNA-like system 
however its particular mechanism has not been yet elucidated.  The basis of the 
prokaryotic RNAi system is the CRISPR loci (clustered regularly interspaced short 
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palindromic repeats) which are complementary to sequences of known prokaryotic 
viruses, transposons and plasmids (Bolotin et al., 2005; Makarova et al., 2006).  Through 
bioinformatics, a number of CRISPR-associated genes (cas genes) have been predicted 
coding for helicases, RNA-binding proteins, nucleases and also a polymerase (Jansen et 
al., 2002; Makarova et al., 2002, 2006).  Through extensive in silico research, it has been 
hypothesized that these predicted cas genes may actually comprise an RNAi-like system 
which aids in the defence of the prokaryotic genome.  The hypothetical mode of action 
has been described by RNA sequences from the CRISPR loci associating with Cas 
proteins which in turn trigger the degradation of the invasive RNA structures Bolotin et 
al., 2005; Makarova et al., 2006).  Experimentally, new evidence suggests the importance 
of these CRISPR loci in prokaryotic viral resistance.  In 2007, Barrangou showed that 
alterations in a prokaryote’s CRISPR sequences lead to the destruction of a corresponding 
viral sequence (Barrangou et al., 2007), however the pathway by which this targeted 
degradation takes place has not been yet determined. 
 
1.2.5 RNA interference in eukaryotes 
The eukaryotic RNAi machinery is complex and plays a role in many different 
cellular processes.  Through the elucidation of this mechanism, a better understanding of 
post-translational gene regulation can be achieved.  It all commences with the production 
of small RNAs, 20-30 nucleotides in size that trigger the cascade.  Currently, three main 
classes of small regulatory RNAs are recognized, namely short interfering RNAs 
(siRNAs), microRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs).  These classes 
differ from one another not only in structure, but also through their mode of action.  Most 
of the proteins that participate in the RNAi pathway in eukaryotes show a distinct 
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conservation in their domains, most importantly for the Argonaute and Dicer proteins 
(Tolia and Joshua-Tor, 2007).  Through the interaction of these important proteins with 
their specific small non-coding RNAs, genomic surveillance and protection against 
transposable elements and viruses is achieved.  The first two classes of small RNAs rely 
on a similar pathway in which the active proteins are Dicer and Argonaute, however in 
the case of siRNAs the result is target mRNA degradation, while the production of 
miRNAs results in translational repression.  The third class of small non-coding RNAs, 
piRNAs are found in animal germ cells and they generally silence retrotransposons and 
are highly active during spermatogenesis. 
 
  1.2.5.1 Post-Transcriptional Gene Silencing in Plants 
The first time an RNAi-like mechanism was reported was in 1990 by Napoli and 
Jorgensen while studying chalcone synthase, a rate limiting enzyme in the anthocyanin 
biosynthesis pathway in petunias responsible for the violet colouration (Napoli et al., 
1990).  Through overexpression, they anticipated a deepening of the violet colour 
however the results showed white flowers with violet patches, a phenomenon coined 
“cosuppression” by the investigators.   
 Three main RNA silencing pathways occur in plants through siRNAs, miRNAs 
and chromatin modification.  The first pathway, post-transcriptional gene silencing 
(PTGS) relies on the production of siRNAs that in turn trigger the degradation of a 
complementary mRNA substrate and it is induced through the production of dsRNAs 
from RNA viruses, transgenic inverted repeats and lastly RNA-dependent RNA 
polymerases (RdRps).  The second pathway relies on the production of endogenous 
miRNAs produced by a Dicer like protein (DCL1) which act in the downregulation of 
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gene expression through translational repression or by triggering degradation of target 
mRNA.  Lastly, the third pathway by which gene regulation is achieved in plants is 
through transcriptional gene silencing (TGS).  This last pathway is initiated by siRNAs 
which couples with heterochromatin, leading to DNA methylation and chromatin 
remodelling ((Chan et al., 2005).  Recent observations have linked the siRNA-directed 
DNA methylation in plants to the process of histone modification in fission yeast 
(Zilberman et al., 2003). 
Studies in the model organism Arabidopsis thaliana unveiled the presence of four 
Dicer like proteins (DCL1-4), 10 Argonaute protein family members, 6 members of the 
RNA-dependent RNA polymerase family and five members of the double-stranded RNA-
binding domain protein family (dsRBP).  The Argonaute family members in A. thaliana 
have some overlap in their function, however, general consensus is that they are the slicer 
components of RISC or RITS complex (RNA-induced transcriptional silencing), the latter 
of which generally is present during specific developmental stages.  The Argonaute 1 
protein in Arabidopsis has been speculated to participate in the RISC complex of the post-
translational gene regulation mechanism.  Evidence supporting this hypothesis came 
through the research of Vaucheret, in which hypomorphic mutants that were created 
continued to accumulate miRNA, however slicing of the target mRNA was not observed 
(Vaucheret et al., 2004).  The question of function overlap between Argonaute in A. 
thaliana was addressed through the creation of Ago1 mutants, which led to defective 
miRNA and siRNA defective phenotypes, suggesting that perhaps Ago1 participates in 
several pathways (Fagard et al., 2000; Vaucheret et al., 2004). 
  The Dicer family in A. thaliana contains four members, all of which may actively 
participate in the silencing of genes via different mechanisms.   Even though four Dicer-
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like proteins have been identified, only two of them, namely DCL1 and DCL3 have been 
characterized and linked to a specific function.  DCL1 protein has been shown to act in 
the production of miRNAs, 21 nucleotides in size, from a source of dsRNA producing 
nearly perfectly matched miRNAs to the targeted sequence (Papp et al., 2003; Xie et al., 
2004).  DCL3 has been implicated in chromatin silencing through the production of 
transposon and retroelement-derived siRNAs.  Moreover, the siRNA products prepared 
by DCL3 are 24 nucleotides in size (Baulcombe, 2004).  The functions of the remaining 
two members of this family, namely DCL2 and DCL4 have been difficult to demonstrate. 
DCL2 has been associated with viral siRNA production however the function of DCL4 is 
still not known (Xie et al., 2004).   
 
1.2.5.2 RNA interference in Invertebrates and Mammals 
Upon the discovery of RNAi in plants, many genetic studies questioned whether or 
not the same machinery is conserved in higher eukaryotes such as invertebrates and 
mammals.  The RNAi mechanism was first observed and characterized in C. elegans 
(Fire et al., 1998). A distinct phenomenon was observed in C. elegans, in which the RNAi 
response seems to be heritable and can be maintained for several generations.  This 
phenomenon has not been encountered in other organisms (Grishok et al., 2000).  PAZ-
PIWI family proteins such as Rde-1 and Rde-4 were also identified and these dsRNA 
binding proteins were found to associate with the only Dicer, Dcr-1 (Kamath et al., 2003; 
Hammond et al., 2001).  The Dicer protein identified in this organism contains a 
conserved DExH box and it is responsible for processing dsRNAs into siRNAs (Tabara et 
al., 2002).  Other RNAi related proteins were also elucidated in through the help of 
mutants, with as many as 27 Argonaute proteins being identified and classified as primary 
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and secondary. The secondary Argonautes have been described to act in the RNAi 
amplification phenomenon found in worms (Steiner et al., 2006; Kamath et al., 2003; 
Vastenhouw et al., 2003).   
The signal amplification was a result of template amplification, and the proteins 
responsible for creating these secondary substrates for the amplified RNAi signal were 
two RNA-dependent RNA polymerases.  These RdRp were ego-1, found exclusively in 
the germline, and rrf-1 in somatic tissues(Smardon et al., 2000; Sijen et al., 2001).  
Mechanistically, it is thought that the products of the Dicer enzyme in concert with the 
mRNA template facilitate binding of these proteins leading to the generation of new 
dsRNA substrates for subsequent Dicer cleavages (Grishok, 2005). 
A key component of the RNAi mechanism was eventually identified in Drosophila 
and its involvement in RISC has been been linked to the slicing of target mRNA with the 
aid of siRNAs (Hammond et al., 2001).  Further evidence on the importance of 
Argonaute involvement in the RNAi mechanism in flies came from embryos lacking 
Ago2, one of the two Argonaute isoforms in flies.  Ago2 mutants were described to have 
the ability to degrade RNA targets using miRNAs specific to those, however they lacked 
the ability to undergo siRNA-directed degradation of such substrates (Okamura et al., 
2004).  Furthermore, Ago1 mutants have been reported to retain their ability to undergo 
siRNA induced degradation, however the miRNA directed target degradation is lost 
(Kataoka et al., 2001).  Both these studies imply that slicer activity is related to both 
Argonaute isoforms, however the exclusive protein associated with target RNA cleavage 
through RNAi is Ago1 (Rand et al., 2004).     
Similarities between the slicer components in flies and humans are remarkable.  At 
the peptide level, Ago1 in flies is related to hAgo2 (human Argonaute 2).  hAgo1, 
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although present, does not display slicer activity, even though it is able to bind single 
stranded and double stranded RNA.  Also, the similarities between itself and its active 
counterpart, hAgo2, at the protein level are staggering (Meister et al., 2004; Liu et al., 
2004).  In 2002, siRNAs 21 base pairs long were shown to interact with human RISC as 
well as causing a distinct knockdown in the gene expression of HeLa cells.  The same 
study also demonstrated that single stranded antisense siRNAs are also capable of gene 
silencing in these cells when phosphorylated at their 5’ end suggesting that the guide 
strand within RISC is a single stranded antisense RNA molecule (Martinez et al., 2002).  
microRNA processing was also witnessed using recombinant dicer protein and 
cytoplasmic extracts from HeLa cells in vitro.  This study effectively demonstrated the 
processing of pre-miRNAs of various lengths into the mature miRNAs 21 base pairs in 
length (Leuschner et al., 2007).  Recently, it was determined that the downregulation of 
Dicer expression in human endothelial cells leads to apoptosis, showing the importance of 
miRNA and siRNA biogenesis in mammalian cells (Asada et al., 2008). 
Studies in other mammalian systems were aimed at elucidating the developmental 
roles of important genes such as Dicer at embryological stages, mirroring the importance 
of tightly regulating pre-miRNAs.  It was shown that a loss of Dicer1 protein is lethal in 
the early developmental stages of mouse development.  The study also demonstrated the 
importance of the Dicer1 protein since the group was not able to create embryonic stem 
cell null mutants (Bernstein et al., 2003).  A recent mouse model study revealed that 
Dicer1 expression is crucial in the normal development of the reproductive tract, 
especially in females (Hong et al., 2008).  Studies in mammalian systems suggest that 
although the RNAi machinery plays an important role in defending the genome, it plays 
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an even bigger part in the normal development of mammals, controlling key genes linked 
to apoptosis. 
 
1.2.6 Applications of RNA interference 
In the past decade, RNA interference has become a powerful tool in the inquiry of 
gene function in different model organisms as it allows for targeted downregulation of 
gene expression.  Due to the simplicity of the method, it quickly became an alternative to 
gene-knockout methods or transgenic animals.  RNAi also permits large-scale functional 
analysis such as a study in C. elegans which isolated mutant phenotypes for almost 1800 
genes (Kamath et al., 2003).  Another successful application of RNAi was shown in D. 
melanogaster aimed at identifying essential signalling cascades and embryonic 
development (Clemens et al., 2000).   
Gene specific therapy may soon become a reality based on the high specificity of the 
target mRNA recognition in diseases in which aberrant protein production disrupts 
cellular processes.  Highly specific siRNA-induced gene silencing was reported in trials 
using Human Embryonic kidney (HEK) 293 cells expressing GFP mRNA, showing that 
while siRNAs specific to the GFP mRNA expressed promotes the active degradation of 
this substrate, no other secondary changes were observed in overall HEK293 gene 
expression (Chi et al., 2003).  Another study showed that the complementarity of siRNAs 
can also be used to target mutant alleles, while allowing for proper expression of the wild 
type allele, offering more evidence of the importance of this technique (Moss, 2003).  
Evolutionarily, the RNAi mechanism was developed as a method to keep guard against 
viral invasion and several experiments have shown the ability of specific siRNAs to 
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inhibit infection by a myriad of viruses, including the Human Immunodeficiency Virus 
(HIV), hepatitis C virus and the poliovirus. 
The main pitfall to this technique is the delivery of siRNAs to the necessary site or 
cells in vivo.  With other organisms such as C. elegans, siRNAs can be introduced in the 
worm through feeding however in mammals the delivery of siRNAs becomes more 
problematic.  Additionally, plasmid systems expressing dsRNA through the head-to-head 
promoter arrangement has been shown to cause downregulation of a target gene in 
organisms such as T. gondii and T. brucei (Al-Anouti et al., 2004; Tschudi et al., 2003).  
A 2007 study showed that the introduction of siRNAs in mammalian systems is 
recognized by the IFN-pathway, which in turn leads to inflammation through innate 
immunity activation.  This phenomenon was observed regardless of the cell line or 
sequence of the siRNA used, determining that siRNAs activated both the IFN-alpha and 
IFN-beta cytokines (Sledz et al., 2003, Kariko et al., 2004).  Due to this sensitivity, better 
delivery methods are necessary in mammalian systems.  Reports of chemical 
modifications to uridines within the siRNA such as the addition of a good leaving group 
to the 2’ position such as fluorine (2’fluoro uridine) may escape detection by the immune 
system (Sioud, 2007).  Other methods of evading the immune system include lipophillic 
vehicles and a new antibody delivery strategy (Song et al., 2005).   
 
1.3 RNAi in protozoan parasites 
1.3.1 Evidence of RNAi in protozoa 
The first account of RNAi in a protozoan parasite came from T. brucei in which 
downregulation of a target gene was achieved, however at the time this phenomenon 
was poorly understood (Ngo et al., 1998).  Upon this discovery, extensive work has been 
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done in protozoans in the generation of vectors capable of inducing an RNAi response.  
The most commonly used method involves the cloning of a gene of interest between 
opposing promoters arranged in a head to head fashion, yielding dsRNA upon 
expression.  Other methods for RNA-induced downregulation include the expression of 
hairpin RNAs or the generation of an inducible system such as the tet-R system which 
allows for dsRNA expression only upon induction (Tschudi et al., 2003; Meissner et al., 
2001).  Through the use of bioinformatics, it was predicted that members of the 
Trypanosomatidae family such as T. brucei and T. congolese appear to be RNAi 
positive, while other members of this family such as T. cruzi and Leishmania major do 
not posses the classical RNAi components (Shi et al., 2004; Ullu et al., 2004).  Recent 
results show that Argonaute1 is an important component in the RNAi pathway of T. 
brucei since depletion of this protein caused an impairment of the RNAi response (Shi, 
et al., 2007).  In apicomplexan parasites, P. falciparum was shown to exhibit dsRNA 
specific downregulation of dihydro-orotate dehydrogenase (DHODH), an important 
enzyme in the pyrimidine biosynthesis pathway (McRobert and McConkey, 2002).  Data 
base mining however failed to show the existence of classical RNAi related genes in P. 
falciparum such as Arognaute, Dicer and RdRp and the observed RNAi effects showed 
in 2002 may possibly be artifacts due to antisense RNA and not an effect of dsRNA.  
The antisense RNA molecule hybridizes with the mRNA molecule preventing the 
initiation of translation (Ullu et al., 2004). 
In the case of G. intestinalis, an RNAi mechanism is evident from data base 
mining, with clear regions for Argonaute and Dicer like proteins being present.  
Recently, the Dicer protein of Giardia was isolated, and its crystallographic structure 
reveals the protein’s ability to generate siRNAs (Macrae et al., 2006). 
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1.3.2 RNAi in T. gondii 
As witnessed in other protozoans, the ability to initiate an RNAi response in the 
presence of dsRNA has been successfully identified, and database mining suggests that T. 
gondii may possess the same ability.  Scanning of ToxoDB resulted in the finding of a 
PIWI protein as well as several dsRBD proteins that may emerge as the Dicer protein in 
this organism.  Furthermore, it was previously reported that the introduction of dsRNA in 
T. gondii elicits the specific degradation of homologous mRNA (Al-Anouti and 
Ananvoranich, 2002; Al-Anouti et al., 2003).  Moreover, a 2006 study showed that by 
lowering the expression of Argonaute protein in transgenic T. gondii, the ability to carry 
out dsRNA induced gene silencing became impaired.   Also, the study suggested that only 
one Argonaute protein may actively participate in the process of gene silencing via a 
dsRNA induced mechanism (Al Riyahi et al., 2006).  Although the hallmark of RNAi 
was not demonstrated, namely the production of siRNAs, the study conclusively 
determined the involvement of a minimal Argonaute protein in dsRNA induced gene 
silencing. 
 
1.3.3 RNAi Machinery in T. gondii 
1.3.3.1 T. gondii Argonaute protein 
Argonaute proteins are the catalytic components of the RNA induced silencing 
complex.  These proteins are generally composed of four domains, namely the N-
terminus, middle, PAZ and PIWI domains.  The presence of a Argonaute protein in T 
gondii has been largely refuted, although it was demonstrated that an Argonaute ortholog 
may be present in T. gondii which is able to participate in the double stranded RNA 
induced silencing (Al Riyahi et al., 2006).  It was also reported that the T. gondii 
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Argonaute protein has high similarities in its structural and functional features with 
eukaryotes as well as bacteria.  The TgAgo cDNA is 1575 nucleotides which encode for a 
524 amino acid peptide, with a molecular weight of 58.5 kDa and a theoretical isoelectric 
point of 9.4.  By Argonaute standards, this protein appears to be very small however it is 
able to interact with dsRNA in the RNAi mechanism (Al Riyahi et al., 2006). 
The lack of a PAZ domain in T. gondii has sparked much debate regarding its activity, 
however it has been shown that although the Argonaute protein of A. fulgidus (AfPIWI) 
does not contain a PAZ domain, its ability in binding single stranded or double stranded 
RNA and DNA is maintained. It has also been shown that structurally, AfPIWI is able to 
adopt an RNase H-like fold, explaining the binding capacity to single and double stranded 
RNA (Parker et al., 2004); (Ma et al., 2005).  Furthermore, in Drosophila, studies have 
shown that recombinant PIWI domains maintain their slicer activity in vitro (Miyoshi et 
al., 2005).   
 
1.3.3.2 Dicer (RNase III) 
Our group has previously shown that data base mining produces several candidates 
for the role of Dicer in T. gondii.  Furthermore, a past member of our lab was also able to 
clone and express the RNase III domain that arose from in silico research.  The 
production of siRNAs has yet to be shown in T. gondii, however experimental evidence 
suggests that through the introduction of dsRNA, gene specific knockdown can be 
achieved (Al-Anouti and Ananvoranich, 2002; Al-Anouti et al., 2003).  This suggests that 
although this particular protein has not been yet characterized, the propensity of it 
carrying a classical role is high.  
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1.4 Objectives 
 From its discovery nearly a decade ago, RNAi has quickly become the leading 
tool in studying the function of unknown genes.  Previous studies in our lab suggest that 
RNA interference is active in T. gondii with some of the pivotal proteins being 
recognized through a bioinformatics approach (Al-Anouti et al., 2003; 2004).  The first 
aim of this study was to use a more in depth bioinformatics based approach to identify 
other possible candidates in the RNAi pathway of T. gondii using well annotated genes 
from other organisms as well as to confirm previous bioinformatic data.  The second aim 
was to show the presence of a double-stranded RNA mediated ribonuclease activity and 
to identify its requirements.  The third objective was to present evidence of siRNA 
formation, therefore proving the existence of an RNAi-like pathway in T. gondii.  The 
fourth aim of this study was to isolate and purify the Argonaute protein present in T. 
gondii and to characterize it. 
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CHAPTER II 
MATERIALS AND METHODS 
 
2.1   Chemicals and Reagents 
Chemicals and reagents that were used in this study are listed below. 
 
Amersham-Pharmacia Biotech (Baie d’Urfe, Quebec). 
T7 RNA polymerase, 2’-deoxyribonucleoside 5’-triphosphates (dNTPs), ribonucleoside 
triphosphates (rNTPs), nitrocellulose membranes, and ECL western blot detection 
reagent. 
Bio-Rad Laboratories (Mississauga, ON) 
Xylene Cyanol, Bromophenol Blue, Coomassie brilliant blue R-250and Bio-Rad protein 
assay dye reagents. 
Invitrogen Corporation (Burlington, ON) 
RNase Out Ribonuclease inhibitor, BL21 (DE3) competent cells 
MP Biomedicals (Ohio, US) 
Cyclohexylaminopropane sulfonic acid (CAPS), N-lauroyl sarcosine 
Promega (Madison, WI) 
Agarose, RQ1 RNase-free DNase, Multicore buffer. 
Roche Diagnostics (Laval, Qubec) 
Taq DNA polymerase 
Sigma-Aldrich (Oakville, ON) 
Acetic acid, ampicillin, chloroform, DNA ladders, dimethylsulfoxide (DMSO), 
dithiothreitol (DTT), diethylpolycarbonate (DEPC), ethanol, ethylenediaminetetra-acetic 
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acid disodium salt (EDTA),  ethidium bromide, formamide, formaldehyde, glycine, 
glycerol, hydrochloric acid, methanol, polyoxyethylene sorbitan monolaurate (Tween-
20), 2-propanol, phenylmethyl sulfonyl fluoride (PMSF), sodium chloride, sodium 
acetate, N,N,N’,N’ tetramethyl ethylenediamine (TEMED), tris-
hydroymethylaminomethane (Tris), Triton X-100. 
USB (Cleveland, OH) 
Boric Acid, Acrylamide, bis-acrylamide, ammonium persulfate (APS), RNase A and 
sodium dodecyl sulphate (SDS). 
 
2.2   Apparatus and instrumentation 
Agarose gel electrophoresis of DNA and RNA was carried out using the Miniature 
Horizontal Gel System MLB-06 from Tyler Research Instruments. AlphaImager™ 2200 
Light Imaging System with AlphaEase software was used to view gels and take images. 
Sodium dodecyl sulfute Polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using the vertical gel electrophoresis system, including all the glasses, Teflon combs and 
spacers, from Bethesa Research Laboratories (BRL). 
     Centrifugations were carried out in J2-HS Centrifuge (Beckman), the desktop 
Eppendorf Model 5415C microcentrifuge from Desaga (Sarstedt Gruppe, Germany), or 
the Br4i centrifuge (Jouan, SA). DNA, RNA and protein concentrations were quantified 
using the Genesys 10 UV-Visible spectrophotometer. The quartz cuvettes used were from 
Sigma. 
PCR reactions were performed using the 20-well Techgene Thermal Cycler 
(Techne, Cambridge, UK). 
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2.3 Parasite strains and culturing conditions 
Two different T. gondii strains were used for this study, namely the RH and Ui.  
RH is a laboratory strain and was obtained from the AIDS Research and Reference 
Reagent Program, NIH. The Ui parasite strain is a stable transgenic strain that was created 
in our laboratory from parental RH, designed to constitutively express double stranded 
RNA homologous to the Uracil phosphoribosyltransferase (UPRT) gene under selection 
with 5-fluoro-2’-deoxyuridine (FDUR), while parasites lacking the plasmid expressing 
dsRNA UPRT will perish under this selection.   
The T. gondii parasites were grown in HFF host cells. These HFF cells were 
grown in Dulbecco’s Modified Eagle Media (DMEM) containing 10% cosmic calf serum 
at 37°C in a 5% CO2 environment. The HFF media was also supplemented with 50 µg/µL 
of streptomycin and 50 units/mL of antibiotic/antimycotic mix. The HFF medium was 
replaced with minimum essential media (MEM) containing 1% dialyzed fetal bovine 
serum (FBS) with appropriate antibiotics prior to parasite infection. Upon lysis of 
infected HFF cells, the parasites were harvested by centrifugation at 4,000×g, washed 
with phosphate buffered saline (PBS), and stored at -20°C 
 
2.4 Plasmid DNA preparation 
Single bacterial colonies were inoculated and grown in 3 mL of LB broth 
containing the appropriate antibiotic of concentrations of 100 µM/mL, after which it was 
incubated overnight at 37°C while shaking at 250 rpm.  1.5 mL of this culture was then 
transferred to a 1.5 mL centrifuge tube and centrifuged at 13000 rpm for approximately 2 
minutes.  The supernatant was aspirated and 100 µL of ice cold 25mM Tris-HCl with a 
pH of 8.0 containing 10 mM EDTA was added, and the pellet was resuspended.  200 µL 
 34
0.2 N NaOH with 1% SDS was added and then the tube contents were mixed by 
inversion, after which they were left on ice for 3 minutes.  150 µL of ice cold NaOAc (pH 
5.2) was added to the tubes, which were then mixed by inversion and left on ice for 
another 5 minutes.  The tubes were then centrifuged at 12000 rpm for 15 minutes at 4 °C 
after which the supernatant was transferred to a fresh tube.  400 µL of TE-buffered 
phenol:chloroform:isoamyl alcohol (25:24:1) was added to the supernatant and the tubes 
were vortexed for 30 seconds, after which they were centrifuged at room temperature at 
12000 rpm for a duration of 5 minutes.  The top aqueous layer was then transferred to a 
fresh tube and 800 µL of 95% ethanol were added to it, following centrifugation at 12000 
rpm for 15 minutes at 4 °C.  The supernatant was discarded and 400 µL 70% ethanol 
were added followed by centrifugation at room temperature for 10 minutes.  The 
supernatant was discarded once again and the pellet was allowed to dry in the fumehood 
for 10 minutes.  Once the pellet had been given enough time to dry, 30 µL buffer 
containing 20 µg⁄ µL RNase A was added and the tubes were then incubated at 37°C for a 
period of 15 minutes. 
 
2.5 Agarose Gel Electrophoresis 
1% agarose gels were prepared (0.4 grams to 40 mL TAE buffer) in order to visualize 
the size of various DNA fragments.  Ethidium bromide was used in order to visualize the 
DNA fragments on the gel and it was added directly to the TAE buffer.  The DNA 
samples were first mixed with 6X gel loading buffer containing 0.25% w/v bromophenol 
blue, 0.25% w/v xylene cyanol FF and 40% w/v sucrose, after which the gel was run at a 
voltage of 120 mV and upon completion the gel was visualized on the AlphaImager 
Imaging System using the provided software. 
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2.6 Restriction Enzyme analysis 
For a 10 µL reaction pool, 2 µL of DNA was incubated with 1 µL of 10X enzyme 
buffer and 0.2 µL enzyme along with 6.8 µL of autoclaved Millipore water.  The reaction 
mixture was incubated overnight at 37°C.  The reaction pool was adjusted accordingly 
depending on the purpose, and post incubation, the fragments may be viewed using the 
agarose gel electrophoresis, they may be gel purified or they may be precipitated using 
ethanol as described in section 2.1. 
 
2.7 Polymerase chain reaction 
 PCR used to generate DNA templates for in vitro transcription was performed in a 
total volume of 50 µL containing 34.1 µL of dH2O, 5 µL of Taq DNA polymerase buffer 
(20 mM ammonium sulphate, 75 mM Tris-HCl, pH 8.8), 5 µL of 25 mM MgCl2, 0.5 µL 
of 2.5 mM dNTP mix, 2 µL of 10 pmol/µL of each oligonucleotide primer (5’ and 3’), 
2µL of cDNA template, and 1U of Taq DNA polymerase. The PCR reaction was carried 
out in the 20-well Techgene thermal cycler, in 25 cycles (94ºC for 15 sec, 62ºC for 15 
sec, 72ºC for 1 min) followed by a final extension step at 72ºC for 5 min. The PCR 
products were purified by phenol:chloroform precipitation and stored at -20ºC until use.  
 
2.8 Phenol:Chloroform Extraction 
DNA/RNA samples were purified by phenol:chloroform extraction. All samples were 
diluted in dH2O to a total volume of 200 µL and mixed with an additional 200 µL volume 
of phenol:chloroform:isoamyl alcohol (25:24:1 (v/v)) by vortexing for 30 seconds. The 
samples were centrifuged at 12,000×g at for 2 minutes at room temperature, and upon 
completion, the top aqueous layer of the suspension was collected in a separate tube, 
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followed by the addition of 0.1 volume of 3 M sodium acetate, pH 5.2, and 2.2 volume of 
95% (v/v) EtOH.  The tubes were gently mixed and allowed to incubate at -20ºC for 20 
minutes causing the precipitation of nucleic acids. The samples were then centrifuged at 
12,000×g for 15 minutes at 4ºC to collect the nucleic acid pellets. The supernatant was 
discarded and the pellets were washed with 2.2 volume of 70% EtOH, followed by 
centrifugation at 12,000×g for 10 minutes at 4ºC. The tubes were inverted and the pellets 
were air dried to remove EtOH traces followed by the addition of 20-30 µL of DEPC 
dH2O. PCR products that were used as templates for in vitro transcription reactions were 
also resuspended in DEPC treated dH2O. 
 
2.9 In vitro transcription 
In order to test the RNA interference capability in T. gondii, several RNA species 
were synthesised by PCR from the UPRT open reading frame (ORF) in T7GGpUC18 
plasmid and the HXGPRT ORF in ptub8MycHisGFP-HX, respectively.  The PCR 
primers and their expected size is shown in the table below.  Upon visualization of the 
complete and correct PCR product, phenol:chloroform extraction was performed in order 
to ensure an RNAse free template for the subsequent steps of in vitro transcription.  The 
in vitro transcription reaction was performed for 4 hours after which the product was 
visualized followed by phenol:chloroform purification.  The concentrations of RNAs 
obtained from in vitro transcriptions were calculated by taking absorbencies at A260 
according to the formula: [RNA] = (A260nm)(dilution factor)(40 µg/mL) for sense and anti 
sense RNA and [RNA] = (A260nm)(dilution factor)(50 µg/mL) for double stranded RNA. 
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Figure 2.2  Visualization of PCR and in vitro transcription products.  Production of 
RNA species from PCR products containing T7 promoter on their 3’, 5’ or both ends:  In 
panel A, the PCR templates were run to validate the size of DNA template encoding for 
UPRT dsRNA (1), UPRT ssRNA (2) and UPRT asRNA (3).  The products run at the 
expected size of approximately 735 base pairs.  Panel B depicts in vitro synthesized 
UPRT asRNA, UPRT ssRNA  and UPRT dsRNA respectively. 
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2.10 dsRNA directed ribonuclease assay 
 This assay was designed to test for the overall RNAi activity of T. gondii.  Two 
different parasite strains, RH and Ui, were used for the assay. Freshly released parasites 
were collected, washed in PBS and resuspended in 60 µL of an assay buffer containing 20 
mM Tris-HCl, pH 7.5, 1 mM DTT in DEPC treated dH2O and supplemented with 5 µL of 
PMSF protease inhibitor. Lysis was performed by sonication at level 5 for 2 pulses of 5 
seconds each (sonication was performed on ice), followed by centrifugation at 13,000×g 
for 15 minutes at 4°C to remove cell debris. Protein concentrations were assessed by 
Bradford assay.  Each assay contained 0.375 - 1 µg of lysate and 65 pmols of ssRNA, 
asRNA or dsRNA (HX or UPRT) respectively, in a total volume of 65 µL at 37°C. 
Samples were taken at different times and the reactions were stopped by the addition of 
loading dye containing EDTA. To check that the substrate was cleaved by T. gondii 
lysates, a negative control containing only the tested RNA species in assay buffer was 
incubated alongside the other reaction pools until the last time point was collected.  
 
 
2.11 dsRNA specific ribonuclease assay 
 This assay was designed to test for the Dicer activity of T. gondii.  dsRNA UPRT  
was prepared as described above, followed by incubation with RH lysates.  The 
concentration of protein and RNA used was determined as described above, and the assay 
used a total of 1 μg of protein lysate with 90 pmols UPRT dsRNA in assay buffer (20 mM 
Tris-HCl, pH 7.5, 1 mM DTT in DEPC treated dH2O).  Time points were collected every 
hour up to 5 hours, followed by 1 aliquot of over night incubation (18 hours).  The 
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samples were then ran on 15% Acrylamide gels at a voltage of 140 V for 1.5 hours, 
followed by Sybr Gold staining and visualization. 
 
2.12     Recombinant protein purification 
2.12.1 Transformation of competent bacteria with plasmids 
BL21 competent cells were transformed with various expression plasmids, 
including those used for the induction and purification of the recombinant protein TgAgo.  
25 μL competent cells were mixed with 2 μL plasmid and allowed to incubate on ice for 
20 minutes.  The transformation reaction was then heat shocked at a temperature of 42°C 
for 45 seconds, after which they were placed on ice for 2 minutes.  400 μL of SOB media 
was heated to 42°C and added to the transformation reaction, after which it was incubated 
at 37°C for 30 minutes, shaking at 250 rpm.  After the incubation step was complete, the 
tubes were centrifuged at 5000 rpm in order to concentrate the transformation products to 
100 μL, after which it was plated on plates containing the appropriate antibiotic at 
concentrations of 100 μg⁄ μL.  The plates were then incubated overnight at 37°C. 
 
2.12.2 GST-TgAgo  and HisTgAgo plasmids 
A graphical representation of the plasmids used may be found in the Appendix 
section.  These plasmids were constructed by Karen Cozens and by Ashley Dresser and 
the full information may be found in their respective thesis. 
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2.12.3 Optimizing protein induction 
Initially, 15 mL LB media were incubated with a single colony of BL21 E. coli 
containing the plasmid of interest was grown overnight at 37°C with 250 rpm shaking, 
after which it was evenly distributed into three 250 mL flasks containing 100 mL LB 
media and allowed to grow until the cultures reached an optical density of 0.4.  Once this 
point was reached, varying IPTG concentrations, namely 1 μM, 5 μM and 10 μM were 
added to each of the three flasks respectively and the cultures were allowed to grow in the 
same conditions for 3 hours.  
 
2.12.4 Bacterial cell lysis 
 To confirm the success of induction, a 1 mL aliquot of induced cell culture was 
tested. The 1 mL aliquot was pelleted by centrifugation at 18,000×g for 5 minutes and the 
pellet was resuspended in 50 µL of MCAC buffer (20 mM Tris-HCl, pH 8.0, 500 mM 
NaCl, 10% glycerol, 1 mM PMSF). The lysate was sonicated at level 5 for 3 pulses of 5 
seconds each (sonication was performed on ice) and centrifuged at 18,030×g for 5 
minutes at 4°C. The supernatant (soluble fraction) was collected, and the insoluble 
fraction was resuspended and sonicated once more following the same procedure as 
above.  
 
2.12.5  Glutathione-agarose purification of GST tagged TgAgo 
After the sonication step, the tubes containing the lysed pellets were centrifuged at 
10000 rpm for 15 minutes at 4°C, after which the supernatant was collected.  1 mL of the 
supernatant was saved for SDS-PAGE analysis, while the rest was incubated with the 
Glutathione-agarose beads. 
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Initially, the Glutathione-agarose beads were washed in Binding Buffer made up of 
10 mM Tris and 150 mM NaCl, after which the supernatant was incubated in the column 
for 3 hours to overnight at 4°C.  When the incubation was complete, 1 mL of the 
incubated supernatant was saved for future SDS-PAGE analysis.  The column was then 
washed three times with 10 mL of Binding buffer containing 1% Triton 100%, and 1 mL 
of each of these fractions was saved.  Elution of the GST tagged proteins was achieved by 
washing the column with 10 mM reduced glutathione in 50 mM Tris-base (pH=9.0).  4 
elution volumes of 1 mL each were saved for SDS-PAGE analysis.  The column was then 
washed according to the manufacturer′s protocol (Sigma). 
 
2.13 Bradford assay 
Protein concentration was determined by the Bradford method using the Genesys 
10 UV-visible spectrophotometer.  Protein samples were diluted in dH2O up to a volume 
of 0.5 mL and mixed with 1.5 mL of diluted Bradford reagent.  Similarly, a set of 
standard protein solutions ranging from 0 - 10 µg/mL was prepared with diluted 100X 
BSA according to Bio-Rad’s Bradford reagent instructions.  All absorbencies were 
measured at 595 nm. A standard curve was constructed to allow subsequent determination 
of the protein concentration in the tested samples (Appendix D).  
 
2.14 SDS-PAGE 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
conducted with a discontinuous buffer system with the stacking and resolving gels cast 
vertically.  The resolving gel solution (2.58 ml ddH2O, 1.8 ml 30% Acrylamide solution, 
1.5 ml 1.0 M Tris pH 8.8, 60 μl 10%SDS, 60 μl 10% ammonium persulfate, 5 μl 
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TEMED) was poured first and left to polymerize before being overlaid by the stacking gel 
solution (1.46 ml ddH2O, 0.25 ml 30% acrylamide solution, 0.25 ml 1.0M Tris-HCl pH 
6.8, 20 μl 10% SDS, 20 μl 10% ammonium persulfate, 3 μl TEMED).  
The protein samples were mixed with gel loading buffer containing 6.25 mM Tris-
HCl (pH 6.8), 2% SDS, 10% glucose, 0.05% Bromophenol blue and 720 mM 2-
mercaptoethanol, boiled for 5-10 minutes and loaded onto the SDS-PAGE gel. The gel 
was run in Tris-glycine running buffer containing 196 mM glycine, 25 mM Tris-HCl (pH 
8.4), 0.1% SDS, at 140 volts until the bromophenol blue dye reached the end of the gel. 
 
2.15     Coomassie brilliant blue staining 
After SDS-PAGE, the gel was submerged in Coomassie staining solution (2.5 g/L 
Coomassie R-250 in 40% methanol and 10% (v/v) glacial acetic acid) and allowed to 
stain for 1 hour upon which it was transferred into destaining solution (40% (v/v) 
methanol and 10% (v/v) acetic acid) until protein bands were clearly seen. The gels were 
visualized and their images stored using AlphaImager 2200 Light Imaging system.  
 
2.16     Solubilization of recombinant protein from inclusion bodies 
A 50 mL aliquot of induced culture was pelleted by centrifugation at 6,500×g for 
15 minutes at 4°C and the supernatant was discarded. The pellet was resuspended in 0.1 
culture volume of IB wash buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1% Triton 
X-100) and the cells were incubated on ice for 30 minutes with 100 µg/mL lysozyme.  
The mixture was then transferred to the French Press and the lysis of the suspended cells 
followed at 1200 psi.  The supernatant was stored for future analysis.  The pellet was then 
subjected to two successive steps of sonication, followed by centrifugation at 10,000×g 
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for 10 minutes and resuspension in 0.1 culture volume of IB wash buffer.  The washed 
inclusion bodies were resuspended in IB solubilization buffer (50 mM CAPS, pH 11.0, 
0.3% N-lauroyl sarcosine, 1mM DTT) to a final concentration of 10 mg/mL and 
incubated at room temperature for 15 minutes. Non-solubilized debris was precipitated by 
centrifugation at 10,000×g for 10 minutes at room temperature and the supernatant 
containing the solubilized protein was collected.  
 
2.17     Protein refolding 
In order to remove the N-lauroyl sarcosine and CAPS detergents, the solubilized 
protein was subjectede to dialysis overnight in 100 volumes of dialysis buffer (20 mM 
Tris-HCl, pH 8.5, 0.1 mM DTT) at 4°C. A second dialysis step was performed with 100 
volumes of dialysis buffer lacking DTT for 6 hours at 4°C followed by a third dialysis 
step overnight in the presence of 1 mM reduced and 0.2 mM oxidized glutathione to 
promote refolding into a native-like structure through disulfide bridge formation.  PMSF 
was added to a final concentration of 10 µg/mL and the final dialysate was stored at 4°C, 
followed by a Bradford assay to determine the protein concentration.   
 
2.18    Western blot analysis 
Proteins resolved by SDS-PAGE were transferred onto a nitrocellulose membrane 
using the Mini-Electrophoretic Blotting System.  Electro-blotting was carried out in 
transfer buffer (192 mM glycine, 25 mM Tris-HCl, pH 7.4, 20% (v/v) methanol) at 80 
Volts for 1.5 hours under constant temperature of 1.5°C. The efficiency of the transfer 
was checked by staining the membrane in Ponceau S stain (30% (v/v) sulfosalicylic acid, 
30% (v/v) trichloroacetic acid, 0.02% (w/v) Ponceau S), followed by blocking over night 
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at 4°C using blocking solution (5% (w/v) skim milk in Tris-Buffered Saline Tween-20 
(TBST)). Two 5 minute wash steps in TBST were performed in order to remove excess 
milk proteins, followed by incubation for 1 hour at room temperature with primary 
antibody in 2% skim milk in TBST, then by a set of four washes in TBST for 15, 5, 5, and 
5 minutes, respectively. The blot was then incubated for 30 minutes at room temperature 
in 2% milk in TBST containing secondary antibody specific to the primary antibody used.   
Another set of four washes in TBST for 15, 5, 5, and 5 minutes, respectively was carried 
out, followed by probing with chemiluminescence reagent.  
 
2.19    Gel shift assay 
In order to determine the binding capacity of the isolated recombinant protein to 
various RNA species, a gel shift assay was performed.  5 μg of isolated recombinant 
protein were incubated with RNA in a buffer consisting of 160 mm NaCl, 30 mM Tris 
(pH 8), 5 mM CaCl2, 0.1 mM EDTA, 0.1 mM DTT and 5% (v/v) glycerol.  The samples 
were first incubated at 37°C for 10 minutes, followed by a incubation period of 20 
minutes on ice.  The samples were resolved on a 6% polyacrylamide non-denaturing gel 
(acrylamide: bisacrylamide 80:1, 0.5X Tris Borate and 5 mM CaCl2).  The gel was run for 
20 minutes at constant voltage (160 V), after which the samples were loaded and the gel 
was ran for an additional 2 hours.  The gel was then stained using Sybr Gold and 
visualized. 
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2.20     RNase A protection assay 
Purified TgAgo was incubated in the same binding buffer as described above with 
ssRNA, followed by the addition 1 μl of diluted RNase A (0.003μg/mL).  The reaction 
mixture was then incubated for 30 minutes at 37°C followed by visualization on a 6% 
denaturing gel (acrylamide: bisacrylamide 80:1, 8 M urea, 1X Tris Borate EDTA and 5 
mM CaCl2).  The gel was ran as described above and visualized using Sybr Gold. 
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CHAPTER III 
RESULTS 
 
3.1 Bioinformatic studies of RNAi components in T. gondii 
RNAi related genes such as a PIWI-PAZ containing protein have been previously 
reported in T. gondii through bioinformatics studies.  Our lab however obtained and 
characterized the Argonaute protein and it was established that it lacks a PAZ domain 
(Al-Riyahi et al., 2006).  Furthermore, preliminary data suggested that this homolog may 
be a ribonuclease slicer component of RNAi in this parasite.  Using a bioinformatics 
approach other putative RNAi components of T. gondii were identified using the well 
described RNAi protein members of C. elegans, and from other organisms.   
 Sequences of well annotated genes were obtained by performing a search in the 
NCBI database and the resulting protein sequences were subsequently used to scan the 
ToxoDB database for putative homologs using the blastp feature.  A descriptive list of the 
genes used and their homologs is displayed in Table 3.1.  It should be noted that the 
searches yielded more than one protein at times however the lowest score was selected in 
choosing possible protein homologs since a low score indicates higher confidence.  As it 
can be seen in Table 3.1, some proteins have high scores, and they can be disregarded as 
possible homologs. 
   The rsd-3 (RNAi spreading defective 3) protein which has been postulated to be a 
nucleoside transporter protein in C. elegans was initially used to scan ToxoDB for 
putative homologs.  EPN3 (epsin 3) protein was identified with high confidence, 
displaying 31% identity to the input sequence.  The database accession number for EPN3 
protein was TGME49_014180.  Even though the confidence score is relatively high and 
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there is some amino acid overlap, it is unlikely that the function of rsd-3 is similar to that 
of EPN3, with the latter being involved in lipid binding.  Next, the dcr-1 (Dicer 1) protein 
sequence was used to obtain possible T. gondii homologs.  22 possible candidates were 
obtained, however most of the scores were largely insignificant.  A putative helicase 
(TGME49_067030) was obtained with the top score and the predicted roles of this protein 
as described by the ToxoDB website include nucleic acid binding, ATP binding, helicase 
activity and ATP-dependent helicase activity.  The same putative helicase was obtained 
when the drh-1 (Dicer related helicase 1) protein sequence was used however the score 
was slightly lower than the previous search.  Moreover, the dicer (qde-3) sequence from 
N. crassa was used and it produced 30 possible candidates.  The most significant 
candidates include 3 putative DEAD/DEAH box helicase (TGME49_064840, 
TGME49_106080 and TGME49_116300), one of the key feature of RNase III domain 
proteins, as well as a putative ATP-dependent DNA helicase (TGME49_059250) closely 
related to RecQ-like protein 5 in Canis familiaris.  Although a total of 5 putative dicer 
candidates have been obtained, it is unlikely that they are all functional proteins, and it is 
expected that if one of these proteins participates the RNAi mechanism of T. gondii, it 
will most likely be one of the DEAD/DEAH box helicase candidates. 
 Next, the mut-14 (MUTator) protein sequence, responsible for transgene 
silencing, was analyzed resulting in 37 candidates, however the top protein score was 
obtained for a putative ATP-dependent RNA helicase (TGME49_026250).  It is predicted 
that this putative protein is able to bind nucleic acids and ATP, carry out helicase activity 
and ATP-dependent helicase activity.  Another RNAi component of C. elegans, namely 
the rha-1 (RNA helicase 1) protein was blasted in ToxoDB, yielding 8 putative homologs.  
The rha-1 protein is generally involved in regulation of transcription, translation and 
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RNA processing, possessing a well defined ATP-dependent DEAD/H box RNA helicase.  
The top candidate was a putative ATP-dependent RNA helicase (TGME49_112280) with 
similar predicted functions to the one described previously. 
 The egl-13 (EGg laying defective) protein sequence was inputted and produced 3 
candidates in T. gondii.  These 3 candidates were remarkably similar in that they were all 
characterized by an HMG-box.  The accession number for the top hit was 
TGME49_063720 and the predicted function for this protein was associated with 
regulation of transcription.  The gfl-1 (human gas41-like) protein has been associated 
with potent RNAi suppression upon its removal, suggesting that it is a very important 
RNAi component in C. elegans.  A single T. gondii homolog to gfl-1 was identified to be 
a hypothetical protein (TGME49_015730).  The predicted function of this hypothetical 
protein was linked to transcriptional regulation. 
 Several key proteins were also tested, namely the alg-1 (Argonaute like 1), alg-2, 
ppw-1 (PAZ-PIWI domain containing), ppw-2 and rde-1 (RNAi deficient 1).  These 
proteins converged on the same T. gondii PIWI-PAZ domain containing protein 
(TGME49_110160).  The Argonaute proteins alg-1 and alg-2 regulate the expression of 
RNA species involved in the proper development of the nematode and are also actively 
implicated in the RNAi mechanism.  The ppw-1 and ppw-2 proteins are involved in 
transposon regulation, while the rde-1 protein has been postulated to participate 
downstream from the siRNA producing step.  Moreover, the rde-1 protein in C. elegans is 
an absolute requirement for RNAi.  It should be noted that the highest probability score 
for the PIWI-PAZ domain containing protein was obtained using the alg-1 sequence, 
suggesting that the Argonaute protein in T. gondii, much like the one in C. elegans 
emerged from a plant lineage. 
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 Searches using the smg-2 (Suppressor with morphological effect on genitalia) 
protein sequence resulted in 8 putative homologs.  Smg-2 in C. elegans is responsible for 
mRNA surveillance, and its top homolog in T. gondii was determined to be a putative 
regulator of nonsense transcripts UPF1 (TGME49_091820).  Another key component of 
the RNAi mechanism surfaced upon searches using ego-1 (Enhancer of Glp-One), rrf-1 
(RNA-dependant RNA polymerase family) and rrf-3 converging on a RNA-dependent 
RNA polymerase domain-containing protein (TGME49_017190).  RNA-dependent RNA 
polymerases play an active role in C. elegans in terms of transitive interference and 
maintenance of somatic and germline RNAi, suggesting that although an amplification in 
the RNAi signal has not been documented in T. gondii, it may have the capability to 
generate dsRNA from ssRNA templates.  Another interesting find was the emergence of a 
SET domain-containing protein (TGME49_057770) from the query of mes-2 (Maternal 
Effect Sterile) and mes-4.  In C. elegans, these proteins actively participate in the 
repression of the X chromosome and chromatin regulation respectively.  Moreover, this 
result is indicative of possible chromatin repression and transgene monitoring in T. 
gondii. 
 The tsn-1 (tudor staphylococcal nuclease) protein was also tested, and surprisingly 
yielded 2 homologs, the most significant of which was the tudor/staphylococcal nuclease 
domain-containing protein (TGME49_038050).  Tsn-1 is generally associated with the 
RISC complex in C. elegans and is required from proper let-7 miRNA function, 
indicating that miRNAs may be present in T. gondii and more importantly, that the RNAi-
like activity observed in this parasite may be due to a similar complex containing both the 
Argonaute and the tudor proteins. 
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3.2 dsRNA-directed ribonuclease activity in T. gondii 
3.2.1 dsRNA-directed ribonuclease activity in Ui, RH and HFF lysates 
To test for the ribonuclease activity, the parasite lines RH and Ui were used.  The 
RH parasite line is the parental line of Ui and it is sensitive to FDUR.  The Ui parasite 
strain is a stable transgenic strain that was created in our laboratory from parental RH, 
designed to constitutively express double stranded RNA homologous to the UPRT gene 
under selection with FDUR, while parasites lacking the plasmid expressing dsRNA 
UPRT will perish under this selection.  Fresh parasite pellets were lysed in an assay 
buffer consisting of 20 mM Tris pH 7.5, 1 mM DTT and a Bradford assay was performed 
in order to quantify the protein concentrations.  Equal protein concentrations of Ui and 
RH (1μg total lysate) were incubated with equal concentrations of ssRNA UPRT (100 
pmols).  Representative gels are displayed in Figure 3.2.  Relative Fluorescence Units 
(RFU) readings were obtained by measuring subtracting the background reading from the 
sample using the ImageJ program.  The dsRNA UPRT producing parasite line Ui exhibits 
a ribonuclease activity specific to ssRNA UPRT.  Rapid cleavage of the substrate was 
observed within the first 10 minutes of the experiment, with an observed rate of 71.8 
μM.min-1.mg-1 (upper panel).  The observed rate in the Ui fraction over the course of the 
experiment was 20.9 μM.min-1.mg-1.  On the other hand, the RH lysates did not show the 
same ribonuclease activity throughout the experiment (lower panel).  This data indicated 
that the parasite unable to express dsRNA UPRT (RH) is unable to exhibit ribonuclease 
activity toward ssRNA UPRT substrate under the tested conditions.  Therefore, these 
assay conditions were used for further studies to evaluate the dsRNA-directed 
ribonuclease activity of T. gondii.   
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Figure 3.2 Cleavage profile of Ui and RH lysates. Assay conditions were initially tested 
to determine if Ui parasite line exhibits dsRNA-directed Ribonuclease activity towards 
the UPRT ssRNA substrate.  UPRT ssRNA was incubated with lysates from Ui and RH 
parasites.  The effect of the RNAi machinery on the UPRT ssRNA substrate is displayed.  
The above data represent an individual experiment only, and the initial rate of degradation 
of UPRT ssRNA substrate is displayed for the Ui parasite line. 
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T. gondii, an intracellular parasite, was cultured on HFF monolayers.  Due to this, 
the observed rate in dsRNA-directed ribonuclease activity may be skewed due to the 
presence of host cell protein contamination.  Although some preliminary data indicate 
that HFF cells displayed a weak dsRNA-directed ribonuclease activity, the capability of 
the HFF lysates to cleave UPRT ssRNA was tested.  To achieve this, three reaction pools 
were set up, one for the Ui parasite line and two for the HFF cell line.  The lysate for one 
of the HFF reactions was supplemented with the initiator (UPRT dsRNA) and incubated 
to allow the formation of potential siRNAs, while the other HFF reaction pool consisted 
of HFF lysate, buffer and UPRT ssRNA. 
The results are displayed in Figure 3.3.  HFF lysates that were not supplemented 
with UPRT dsRNA lacked the capability of cleaving the UPRT ssRNA substrate (middle 
panel).  When HFF lysates were pre-incubated (primed) with UPRT dsRNA, degradation 
of target UPRT ssRNA was observed.  The observed cleavage rate obtained was 16.8 
μM.min-1.mg-1 (bottom panel). Furthermore, the Ui lysates displayed the highest observed 
dsRNA-directed ribonuclease rates calculated to be 48.8 μM.min-1.mg-1 (upper panel).  
The data suggests that the ribonuclease activity monitored here was due to that of the Ui 
lysates, with the HFF lysates displaying minimal activity when primed. 
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Figure 3.3 dsRNA-induced ribonuclease activity in HFF cells. Analysis of the 
dsRNA-directed ribonuclease activity in the Ui parasite line alongside the HFF host cells.  
65 pmol of UPRT ssRNA substrate were added to 0.125 μg lysates from Ui parasites, as 
well as to primed HFF lysates (UPRT dsRNA pre-incubated) and HFF lysates.  The data 
was obtained from one experiment and the observed rates were calculated for each lysate. 
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3.2.2 The requirements of dsRNA-directed ribonuclease activity 
Earlier studies in model organisms such as C. elegans and Drosophila showed the 
importance of divalent metal ion cofactors, namely magnesium ions, in the classical 
RNAi pathway of these.  To determine whether magnesium ions play a role in the 
dsRNA-directed ribonuclease activity observerd in T. gondii, an experiment was designed 
in which three Ui cell free lysates were respectively (i) unsupplemented, (ii) 
supplemented with EDTA in order to chelate divalent ions present, and (iii) supplemented 
with magnesium chloride.  The results are displayed in Figure 3.4.  The chelation of 
divalent ions through the addition of EDTA suppressed the cleavage of UPRT ssRNA 
target (middle panel), while the addition of MgCl2 enhanced the cleavage of UPRT 
ssRNA target (bottom panel) with respect to the untreated Ui lysates (top panel).  
Furthermore, the calculated cleavage rate for the MgCl2 supplemented Ui lysates was 33.6 
μM.min-1.mg-1 with respect to the 20 μM.min-1.mg-1 observed in the untreated reaction 
pool indicating that the addition of magnesium ions enhances the cleavage of UPRT 
ssRNA substrate.   
The experiment was performed in triplicate however the results show some 
variation in their observed rates.  The observed rates over the three trials were 33.6 
μM.min-1.mg-1, 77.5 μM.min-1.mg-1 and 37.5 μM.min-1.mg-1 respectively.  This 
significant deviation can be attributed to the quantification method used and the 
inaccuracy of the relative fluorescence unit readings.  This can also be seen in the middle 
panel in which Ui lysates were pre-treated with EDTA, and although no cleavage is 
taking place, the fluorescence unit readings suggest an increasing trend.  This increasing 
trend suggests that target RNA was added over the time course of the experiment 
however this is not the case. 
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Figure 3.4 Effects of divalent ions on dsRNA-directed ribonuclease activity. Lysates 
were pretreated for 30 minutes with EDTA (middle panel) or MgCl2 (lower panel) and 
UPRT ssRNA cleavage was tested with respect to the control Ui (upper panel).  65 pmol 
of UPRT ssRNA substrate were added to 0.125 μg lysates from Ui parasites.  Although 
the experiment was performed in triplicate, only representative gel images are shown 
above.  Large variations within the readings were observed hence the rates were 
calculated for each individual experiment. 
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3.2.3 Specificity of dsRNA-directed ribonuclease activity in T. gondii 
It has been previously reported that the dsRNA-directed ribonuclease in many 
organisms is highly specific and can be directed for homologous mRNA (Martinez et al., 
2002).  In the second step of the classical RNAi mechanism, an Argonaute protein 
promotes RISC complex formation through binding to siRNAs (Ma et al., 2005); (Preall 
et al., 2006). Upon formation, the passenger strand (sense strand of siRNA) is expelled, 
leaving behind the guide strand (antisense strand).  Moreover, it has been shown that this 
preferential loading takes place on the RISC complex and the targeted RNA specie is 
generally the sense strand RNA (Ma et al., 2005).  
In order to test the specificity in the dsRNA-directed ribonuclease activity of T. 
gondii, Ui lysates were incubated with full length UPRT ssRNA and UPRT asRNA 
respectively for 2 hours.  Figure 3.5 shows representative gel images depicting the 
preferential cleavage by the dsRNA-directed ribonuclease activity, completely degrading 
the UPRT ssRNA, while leaving the UPRT asRNA intact for the course of the 
experiment.  This specificity in cleavage activity can be attributed due to the fact that the 
UPRT ssRNA mimics the normal mRNA of this gene allowing its specific degradation 
(upper panel), while the UPRT asRNA is unable to bind to the siRNAs available (lower 
panel).  Another observation that arises from this experiment is that due to ssRNA 
degradation, the siRNA moiety that aids in the degradation of the substrate has to be the 
antisense siRNAs produced in the Ui line.  The observed cleavage rate in this experiment 
was 36 μM.min-1.mg-1.  The triplicate average rate was 35.2 ± 2.4 μM.min-1.mg-1. 
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Figure 3.5  Substrate specificity for dsRNA-directed ribonuclease activity. Full 
length UPRT ssRNA (panel A) and UPRT asRNA (panel B) were tested with the Ui 
parasite line.   This was done to determine whether or not preferential targeting of 
substrate RNA takes place within the dsRNA-directed ribonuclease activity of T. gondii.  
65 pmol of UPRT ssRNA and UPRT asRNA substrate, respectively were added to 0.125 
μg lysates from Ui parasites The gels above are representative of only one experiment 
performed.  The observed cleavage rate in this experiment was 36 μM.min-1.mg-1.  The 
triplicate average rate was 35.2 ± 2.4 μM.min-1.mg-1. 
 
 60
3.2.4 Inducing dsRNA-directed ribonuclease activity in RH lysates 
 The inability of the RH lysates to undergo dsRNA-directed ribonuclease activity 
towards a target RNA was documented in section 3.1. However the parental strain RH 
should have the capability to exhibit dsRNA-directed ribonuclease activity if the dsRNA 
precursors are provided.  To verify this, RH lysates were pre-incubated with UPRT 
dsRNA 30 minutes prior to the addition of ssRNA.  Additionally a reaction pool 
consisting of Ui lysate was used as a control.  Representative gels are displayed in Figure 
3.6.  These gels distinctly show a cleavage of target UPRT ssRNA substrate in both the 
untreated Ui and the UPRT dsRNA primed RH reactions with calculated rates of 44 
μM.min-1.mg-1  and 59.2 μM.min-1.mg-1 respectively.   This suggests that once the dsRNA 
precursor is present, the RH lysates have the capability to recognize and cleave the 
ssRNA substrate, provided that it is homologous to the initiator.   
 A close correlation between the Ui and the primed RH lysates also appeared upon 
the completion of several trials.  The observed average rate for the Ui lysates was 
calculated to be 44.09 ± 8.06 μM.min-1.mg-1, while the observed average rate for the 
primed RH lysates was 41.33 ± 8.67 μM.min-1.mg-1.   The variation between the two 
observed rates is largely insignificant, suggesting that the cleavage of the UPRT ssRNA 
substrate is due to the production of siRNAs from a UPRT dsRNA precursor.  
Furthermore, this suggests that mechanistically, the same set of proteins act on the target 
RNA in both lysates given the proximity in the two rates observed. 
 
 
 
 61
RH
Ui
0                                                   120  (min)
0                                                   120  (min)
UPRT ssRNA
UPRT ssRNA
y = -0.8642x + 142.74
R2 = 0.9339
0
50
100
150
0 50 100
Time (min)
R
FU
59.2 μM.min-1.mg-1
44 μM.min-1.mg-1
y = -0.8492x + 94.843
R2 = 0.9389
0
50
100
150
0 50 100
Time (min)
R
FU
Figure 3.6 Effect of priming RH lysates.  Previously it was observed that pre-incubation 
of HFF lysates with UPRT dsRNA promotes dsRNA-directed Ribonuclease activity in 
these lysates, hence RH lysates were also tested for this by pre-incubating them with 0.5 
pmols UPRT dsRNA.  65 pmol of UPRT ssRNA substrate were added to 0.125 μg lysates 
from Ui parasites and RH parasites respectively. Priming of RH lysates with UPRT 
dsRNA promotes cleavage of target UPRT ssRNA substrate (lower panel).  The above 
gels were obtained from a single experiment, however this was performed in triplicate.  
The observed average rate for the Ui lysates was calculated to be 44.09 ± 8.06 μM.min-
1.mg-1, while the observed average rate for the primed RH lysates was 41.33 ± 8.67 
μM.min-1.mg-1.    
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To test whether this observed cleavage of the target UPRT ssRNA is a direct 
result of the added UPRT dsRNA, an experiment was designed in which the initiating 
dsRNA specie was tested.  Two reaction pools containing 0.25μg total RH lysates were 
pre-incubated with UPRT dsRNA and HX dsRNA respectively.  To these reactions, 50 
pmols of HX ssRNA substrate were added. Gel representatives of this experiment are 
shown in Figure 3.7.  In the upper panel of Figure 3.7, no cleavage was observed based 
on the relative fluorescence unit readings, which show an increasing trend as time 
elapses.  The lower panel of the same figure however displays target HX ssRNA 
degradation caused by the homologous inducer, HX dsRNA.  The observed rate for this 
last experiment was 36.6 μM.min-1.mg-1, suggesting that the value falls within the rates 
obtained previously for the Ui lysates and the RH lysates that were primed with UPRT 
dsRNA.  This result indicates that the homology between the inducing specie and the 
target RNA specie is a key aspect to the ribonuclease activity observed. 
Similarly, RH lysates were primed with HX dsRNA and tested against UPRT 
ssRNA and UPRT asRNA (Figure 3.8) in order to show the role of homology between the 
initiator molecule and the target molecule.  Representative gels are shown Figure 3.8 and 
no ribonuclease activity is detected in either reaction.  This is due to the incompatibility 
of siRNAs produced from HX dsRNA and the substrates tested, which serves as evidence 
for a highly specific RNAi like mechanism in T. gondii that relies heavily on the 
complementary of siRNAs and the specific target ssRNAs. 
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Figure 3.7.  Initiator specificity in dsRNA-directed ribonuclease activity.  Panel A 
depicts 0.125 μg RH lysates pre-treated with 0.5 pmols of UPRT dsRNA for 30 minutes, 
after which 50 pmol HX ssRNA substrate was introduced.  50 pmols HX ssUPRT 
substrate were then added to each reaction.  Panel B shows RH lysates primed with 0.5 
pmol HX dsRNA for 30 minutes, upon which HX ssRNA substrate was added to the 
reaction.  Degradation is observed only in panel B.  The above gel images are obtained 
from a single experiment. 
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Figure 3.8  Initiator and substrate specificity in dsRNA-directed ribonuclease 
activity.  RH lysates were primed with 0.5 μg HX dsRNA and tested against UPRT 
ssRNA and UPRT asRNA in order to show the role of homology between the initiator 
molecule and the target molecule.  RH lysates were pretreated with HX dsRNA for 30 
minutes, after which 50 pmol UPRT ssRNA (top) and 50 pmol UPRT asRNA (bottom) 
substrates was introduced.  No degradation is observed in either reaction. 
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3.3 dsRNA-specific Ribonuclease Activity in T. gondii 
 One of the hallmarks of the classical RNAi mechanism is the conversion of long 
double stranded RNA into siRNAs.  A set of putative dicer proteins have been reported in 
T. gondii through bioinformatics, however they remain uncharacterized.  Dicer like 
enzyme activity which produces the siRNA substrate was evaluated. 
 
3.3.1 Production of siRNA from dsRNA 
In this study, RH lysates were incubated with UPRT dsRNA over the course of 18 
hours with aliquots removed at different time intervals.  A total 1 μg of lysate was 
incubated with 35 pmols UPRT dsRNA in assay buffer containing 20 mM Tris, 1mM 
DTT, pH 7.5.  The reaction was stopped by the addition of equal volume of loading dye.  
 Figure 3.9 displays the time course degradation of UPRT dsRNA.  From this 
figure, a distinct band cannot be observed anywhere in the region of 21-26 nucleotides, 
however the smear is a direct result of the degradation.  Furthermore, by comparison to 
earlier time points, the 18 hour mark displays a distinct accumulation of product between 
the primer derived marker region consisting of 20 and 39 base pairs respectively.  The 
bottom part of the graph was further altered to display the observed accumulation effect 
(Panel A). 
The same experiment was performed in panel B, however this yielded different 
results.  Under the same assay conditions, a distinct accumulation of product accumulates 
(denoted by the asterix sign) in a region much higher than the expected region of 21-39 
nucleotides, however no siRNAs are visible.  
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Figure 3.9 Production of siRNAs from long dsRNA precursors.  Time course 
degradation of full length UPRT dsRNA in the presence of RH lysate was observed.  A 
total 1 μg of lysate was incubated with 35 pmols UPRT dsRNA, upon which aliquots 
were removed at pre-determined times.  The last lane consists of 2 primers of known size, 
39 base pairs and 20 base pairs respectively which serves as a ladder.  A distinct 
accumulation of siRNA-like molecules is observed above the 20 base pair primer in the 
last lane.  Furthermore, the second gel depicts the formation of a intermediate RNA 
specie, possibly due to the dsRNA-specific Ribonuclease activity in T. gondii.  The last 
lane was assigned to UPRT dsRNA that was not incubated with lysates. 
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3.4 TgAgo recombinant protein expression and purification 
The Argonaute protein in T. gondii has not yet been characterized in detail. With 
the use of a GST-TgAgo and a His-TgAgo construct, we aimed to obtain the protein in 
high quantity and in its active state to test its binding capacity to RNA species and to 
obtain kinetic insight into the overall mechanism.   
3.4.1 Optimization of GST-TgAgo induction in E. coli  
In order to over-express the protein of interest, the IPTG inducer concentration 
was tested to determine the lowest effective concentration at which over-expression was 
taking place.  To achieve this, different concentrations of IPTG, ranging from 5 µM to 
100 µM, were used to induce equal volumes of E.coli cultures at an optical density of 0.6.  
Upon induction, the bacterial cultures were incubated for a further 3 hours at 37°C, after 
which they were collected by centrifugation.  Each individual culture was then lysed by 
sonication and the supernatant and the pellet were isolated through centrifugation.  A 
small aliquot of each supernatant and pellet were then treated with SDS loading dye, ran 
on a 10% polyacrylamide gel and stained with Coomasie Brilliant Blue in order to 
visualize the protein of interest.  Initially, the experiments were carried out for a GST-
tagged version of TgAgo, which can be seen at 89 kDa on the Coomasie stained gels.  
From this experiment, it was found that optimal induction was achieved using 5 µM of 
IPTG however a more worrisome outcome was the fact that the majority of the protein of 
interest was found in the pellet or inclusion bodies.  As a control, an uninduced sample 
was visualized along side to the induced cultures, and as expected, no prominent bands 
around 89 kDa can be observed (Figure 3.10). 
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Figure 3.10 Optimization of IPTG concentrations.  E. coli cells were grown to an OD 
of 0.6, after which they were subjected to different IPTG concentration treatments as 
indicated in the table above.  It was observed that the induced protein localizes into 
inclusion bodies. 
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Due to the abundant formation of inclusion bodies containing the protein of 
interest, several other factors must be altered in order to achieve protein solubility since 
solubility would imply a native like structure for TgAgo.  Another parameter that can be 
altered is the optical density at which the E. coli cells are grown.  Bacterial cultures were 
grown to optical densities of 0.4, 0.6 and 0.8, measured at A600, after which they were 
induced with the optimal 5 μM IPTG observed in the previous experiment.  Upon 
induction, these cultures were allowed to incubate for the appropriate time upon which 
the bacteria were collected as described above.  An aliquot of uninduced bacterial culture 
was saved and ran alongside the induced samples which would serve as an induction 
control.  The induced samples were further separated in supernatant and pellets in order to 
check for the emergence of inclusion bodies containing the protein of interest.   
 From Figure 3.11, it is observed that optimal induction takes place at the first two 
optical densities of 0.4 and 0.6 however the TgAgo protein is still being packaged into 
inclusion bodies.  Insignificant levels of TgAgo can be visualized in the supernatant 
fraction.  To avert inclusion bodies, a third experiment was designed in which the 
induction temperature was tested.  Hypothetically, if E. coli cells are induced at a minimal 
optical density with a minimal concentration of inducer at low temperatures, proteins that 
usually associate into inclusion body aggregates tend to become more soluble. 
 To test the effect of temperature on induction and to assess whether the protein of 
interest is becoming soluble, two E. coli cultures were grown to an OD of 0.4, followed 
by induction with 5 μM IPTG.  Upon induction, the two cultures were incubated at room 
temperature (25°C) and at 37°C. 
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Figure 3.11 Optimization of bacterial growth and temperature.  The optical density 
and temperature parameters were altered to determine if an increase in solubility is 
observed on TgAgo.  It was observed that the induced protein localizes into inclusion 
bodies. 
 71
The Coomassie stained gel in Figure 3.11 reveals that there is no clear distinction 
between the supernatant samples of the induced cultures and the uninduced culture, with 
the protein of interest, TgAgo was still found in the inclusion body aggregates.  
Theoretically, the factors that affect the induction of a protein of interest in E. coli are 
optical density of the bacterial culture, the temperature at which the induction is taking 
place, the induction time and inducer concentration.  The only parameter that remained to 
be tested was induction time.  For this, bacterial cultures were grown to an optical density 
of 0.4, after which they were induced with 5 μM IPTG and further incubated for time 
periods of 3 hours, 5 hours, 7 hours and overnight, both at 37 °C as well as room 
temperature.  The results revealed that the protein in question still localized into inclusion 
bodies.   
Several experiments were then designed in order to obtain the protein of interest 
in the soluble fraction.  The optical densities of cultures taken were 0.4, 0.6 and 0.8 
respectively, all induced with varying IPTG concentrations, after which they were 
incubated at different times and different temperatures.  This mix and match approach did 
not yield any significant results as the pattern of insoluble GST-TgAgo continued to 
emerge.  It should be noted that the same experimental approach was taken when dealing 
with the His tagged version of the protein of interest and the results demonstrated that the 
His-TgAgo protein is packaged into inclusion bodies as well.  Figure 3.12 exemplifies the 
change in only one parameter, namely the IPTG concentration, while performing the 
induction at room temperature, overnight. 
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Figure 3.12 Protein over-expression at room temperature.  Induction at room 
temperature, overnight with varying IPTG concentrations.  It was observed that the 
induced protein localizes into inclusion bodies. 
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3.4.2 Solubilization of inclusion bodies and refolding 
Harvested inclusion bodies from an induced culture were washed several times 
and then solubilized under mildly denaturing conditions at pH 11.0 maintained by CAPS 
zwitterionic buffer. N-lauroyl sarcosine detergent was then added in order to disrupt 
hydrophobic aggregation, a key aspect of inclusion bodies. A reducing agent such as DTT 
was added in order to disrupt intermolecular disulfide bridges. At this point, the protein 
was collected and visualized with the use of Coomassie stain on a 10% polyacrylamide 
gel. 
Due to the large number of proteins present in the newly solubilised fraction, 
further purification was required.  The GST-TgAgo protein that was obtained was then 
succumbed to dialysis in order to remove the N-lauroyl sarcosine detergent, as it might 
interfere with the binding between the glutathione resin and the GST tag in subsequent 
purification steps.  Dialysis was performed 3 times in a buffer containing 10 mM Tris and 
150 mM NaCl of pH 7.4.  The results of this are displayed in Figure 3.13.  Further 
purification was attempted through the GST tag, however no binding between the resin 
and the tagged protein occurred.  This may be due to misfolding of the tag, and a GST-
Tag assay was performed in order to check the quality of the tag.  The substrate used in 
this particular assay was 1-chloro-2,4-dinitronbenzene (CDNB), the reaction was 
monitored at 340 nm and the change in absorbency was directly proportional to the 
amount of active GST tag in the sample.  Upon completion of this assay, it was 
determined that the GST tag on the fusion protein was indeed damaged or misfolded, 
since no relative change in absorbance occurred. 
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Figure 3.13 Solubilization of Inclusion Bodies.  The process of solubilisation of 
inclusion bodies was successful and performed with minimal loss of protein during the 
wash steps. 
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3.4.3 His-TgAgo solubilisation from inclusion bodies and protein refolding 
Although previous experiments have also shown that the His version of TgAgo is 
associated with inclusion bodies purification of HisTgAgo becaome more attractive due 
to the relatively small size of the tag and the availability of a reduced and oxidized 
glutathione pairs which can be used in the protein refolding step.  The bacterial culture 
was grown to an OD of 0.4, after which it was induced with 5 μM IPTG and the bacterial 
pellet was collected through centrifugation.  Cellular lysis was performed using the 
French Press, and after several washing steps using the CAPS buffer discussed 
previously, the inclusion bodies were harvested.  The inclusion bodies were then 
solubilised via the N-lauroyl sarcosine method, after which two dialysis steps were 
performed in order to remove the detergent used.  Lastly, three additional dialysis steps 
were performed using the reduced and oxidized glutathione pair in order to promote 
intramolecular disulfide bridge formations and to promote the isolated proteins to fold 
back to their native conformation.  A Bradford assay was conducted in order to determine 
the concentration of the proteins obtained from the inclusion bodies.  A volume of 10 mL 
was isolated, with a concentration of 0.4325 μg/μL for a total of 4.325 mg of protein.  A 
Coomassie stain was then used to assess the purity of the sample, which can be seen 
below (Figure 3.14).  Also, the isolated protein was subjected to Western blot analysis 
with a primary antibody specific to the His sequence and the results show that a protein is 
recognized at the expected molecular weight of 62.5 kDa (Figure 3.14).  Mass 
spectrometry was then used to identify the protein that emerged during the western blot 
analysis and it was concluded that the protein isolated was indeed His-TgAgo. 
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Figure 3.14 Detection of His tag via anti-His antibody.  Panel A depicts the successful 
solubilisation of His-TgAgo visualized on a Coomassie stained gel.  The purity of this 
was assessed at 90%.  Panel B represents the Western Blot analysis of the isolated protein 
which was tested against anti-His antibody. 
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3.4.4 RNA binding capacity of TgAgo 
Although the TgAgo protein was isolated and purified from inclusion bodies, the 
protein refolding protocol used should have, in theory, promoted the formation of 
disulfide bridges and in turn the folding of the protein into a native-like structure.  To test 
the binding capacity of HisTgAgo to RNA species, an RNase A protection assay was 
performed. 
 This assay relies on the ability of a protein to bind target RNA, thus protecting it 
from subsequent RNase A addition through its binding interaction.  Two unrelated 
proteins were used for this particular experiment, namely PDI and BSA.  From Figure 
3.15 it can be seen that HisTgAgo does not display any binding affinity towards the full 
length ssRNA substrate, while PDI and BSA show some affinity towards the substrate.  
Interestingly enough, although the protection did not take place for the full length UPRT 
ssRNA, however it was clear that the purified Argonaute protein offered some protection 
towards smaller fragments as it can be seen in Figure 3.15.  Moreover, by incubating the 
recombinant protein with RNA alone (lane 3), it becomes clear that the degradation is 
caused by the addition of RNase A and that the HisTgAgo protein is not the culprit. 
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Figure 3.15 RNase A protection Assay.  Proteins were pre-incubated with 5 pmol UPRT 
ssRNA for 30 minutes, followed by the addition of 1μL RNase A (0.003μg/mL).  Lane 5 
indicates that the isolated protein does not protect the full length ssRNA specie from 
degradation, however it does offer some protection to cleaved portions of the substrate as 
indicated by the asterix symbol.  Furthermore, HisTgAgo is not responsible for this 
observed cleavage (lane 3). 
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3.4.5 Ribonuclease activity of TgAgo 
Having observed that the recombinant protein is unable to protect target RNA 
from degradation by RNase A, another experiment was performed in order to determine 
whether it has any sort of binding affinity to RNA.  To do this, a gel shift assay was 
performed in which varying concentrations of Argonaute protein (0.5 to 10 μg) were 
incubated with 3 pmols of ssRNA respectively.  The different aliquots were ran on a non 
denaturing polyacrylamide gel, with the results shown in Figure 3.16. 
As displayed in Figure 3.15 there does not seem to be any binding interaction 
between the purified recombinant protein and ssRNA due to the first lane (control) 
running at the same size with the other ones. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80
1        2        3       4       5       6        7       8   9
ssRNA + Buffer9
ssRNA + 10 μg HisTgAgo8
ssRNA + 8 μg HisTgAgo7
ssRNA + 6 μg HisTgAgo6
ssRNA + 4 μg HisTgAgo5
ssRNA + 2 μg HisTgAgo4
ssRNA + 1 μg HisTgAgo3
ssRNA + 0.5 μg HisTgAgo2
ssRNA1
SampleLane
Figure 3.16 Gel shift assay.  Varying concentrations of purified TgAgo protein was 
incubated with UPRT ssRNA (5 pmol/ well).  The mixture was allowed to incubate on ice 
for 30 minutes.  No significant changes are observed between the control lanes (1 and 9) 
and the rest of the gel. 
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CHAPTER IV 
DISCUSSION 
 
4.1 Bioinformatic studies of RNAi components in T. gondii 
 Through bioinformatic studies, several possible components responsible for the 
RNAi activity in T. gondii have been identified.  Well annotated genes from the C. 
elegans RNAi pathway were used in order to determine the presence of homologs in T. 
gondii.  The NCBI database was scanned for the known protein sequences and fed back 
into ToxoDB using the blastp feature.  This feature searches for similarities between the 
known sequences and the Toxoplasma genome.  Several genes of interest surfaced 
through these searches, the most important of which were determined to be an RNA-
dependent RNA polymerase (TGME49_017190), a PIWI-PAZ domain containing protein 
(TGME49_110160) as well as four possible candidates for Dicer (TGME49_064840, 
TGME49_106080, TGME49_116300 and TGME49_067030).   
 The RNA-dependent RNA polymerase was obtained through independent 
searches using sequences of known RdRps from C. elegans, namely rrf-1 and rrf-3. The 
same protein surfaced when ego-1, a protein associated with regulation of 
spermatogenesis, was used.  The highest confidence score was obtained using the rrf-3 
protein sequence, which has a role in somatic RNAi in C. elegans.  The finding of a 
RNA-dependent RNA polymerase suggests that T. gondii may have the capability to 
create double stranded RNAs from single stranded RNAs (generally antisense) to provide 
the dsRNA substrate for the dicer protein.  Moreover, in the well defined C. elegans 
RNAi response, these proteins have been associated with signal amplification, and the 
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substrates produced by these are generally associated with secondary Argonaute proteins 
in the RNAi cascade (Grishok, 2005).   
The PIWI-PAZ domain containing protein that was identified in this study was 
obtained through several searches of related proteins in C. elegans.  These proteins 
included alg-1, alg-2, ppw-1, ppw-2 and rde-1.  The highest homology of the Toxoplasma 
Argonaute protein was to the alg-1 protein, although the alg-2 is also closely related.  It 
has been previously shown that some important metabolic enzymes in Toxoplasma gondii 
are closely related to plant homologs, and the fact that the Argonaute protein obtained 
here is also linked to the Argonaute (plant) like 1 and 2 of C. elegans suggests  a strong 
link to its plant lineage.  
The Argonaute protein obtained through the blastp feature of ToxoDB has been 
previously identified and partially characterized by one of our lab members, indicating 
that the protein itself lacks the PAZ domain when transcribed (Al Riyahi et al., 2006).  
The PAZ domain is not a requirement for slicer activity, as was shown in studies carried 
out with Drosophila mutants (Miyoshi et al., 2005).  Furthermore, ToxoDB predicts that 
the identified Argonaute protein will interact with double stranded RNA, suggesting that 
it may be functional. 
The search for a RNase III domain ribonuclease involved the use of protein 
sequences from C. elegans, namely dcr-1 and drh-1, as well as the dicer protein sequence 
from N. crassa, qde-1.  Using the first two protein sequences, a putative helicase protein 
emerged as a possible candidate, and upon closer inspection, it was determined that it 
carries a DEAD/H box helicase domain, a key feature of Class 3 RNase III proteins.  
Furthermore, the three dicer candidates obtained using the N. crassa dicer sequence all 
carried the signature DExD/H box helicase motif documented in Class 3 RNase III 
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proteins.  Interestingly enough, studies in Giardia revealed that this lower eukaryote lacks 
the DExD/H box helicase feature (Macrae et al., 2006), which makes these findings even 
more intriguing due to the evolutionary proximity between Toxoplasma and Giardia.  It 
should be noted that a putative ATP-dependent DNA helicase also surfaced when the 
qde-3 protein sequence was used, however it is unlikely that this protein is a T. gondii 
dicer candidate since the well preserved motif is not present, it may however play a role 
in transcriptional regulation. 
Another important feature of RNAi was identified through this work, namely the 
tudor staphylococcal nuclease domain-containing protein (TGME49_038050). This 
protein was identified using the protein sequence of tsn-1 of C. elegans, which has been 
described to associate with the RISC complex and to regulate the activity of let-7 
miRNAs.  Since several components of the classical RISC complex have been identified, 
it is likely that the T. gondii RNAi mechanism also involves a gene silencing complex 
containing both the tudor protein and the Argonaute protein described above for its 
activity. 
Other important proteins found in this study include two putative ATP-dependent 
RNA polymerases (TGME49_026250 and TGME49_112280) found by using the C. 
elegans protein sequences of mut-14 and rha-1, which are involved in transgene silencing 
and regulation of transcription respectively.   The second putative protein carries a well 
defined ATP-dependent DEAD/H box RNA helicase domain and it is predicted to bind 
nucleic acids and ATP and also carry out helicase activity in an ATP dependent manner.  
Using this approach, a homolog for smg-2 was also identified in T. gondii.  The C. 
elegans smg-2 protein is responsible for mRNA surveillance, and interestingly enough, 
the top hit obtained through this homology search was a putative regulator of nonsense 
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transcripts UPF1 (TGME49_091820).  A protein which may play an active role in 
chromatin repression and transgene monitoring was also identified, namely the SET-
domain containing protein (TGME49_057770).  This protein was identified using the 
mes-2 and mes-4 C. elegans protein sequences which perform similar roles to the ones 
described above. 
 
4.2 dsRNA-directed ribonuclease activity in T. gondii lysates 
4.2.1 dsRNA-directed ribonuclease activity in Ui, RH, and HFF lysates 
 The Argonaute protein has been identified as a major component of RISC, and 
without it, the organism loses its ability to perform siRNA mediated mRNA degradation 
(Liu et al., 2004); (Meister et al., 2004).  The bioinformatic evidence coupled with our 
preliminary data prompted the investigation of the RNAi mechanism and the Argonaute 
protein in T. gondii. 
 In vitro assays were then conducted to show the specificity of the RNAi activity in 
T. gondii with respect to the initiator, target substrate and the role of metal ions.  A 
primary experiment in which lysates from the Ui and RH parental strains were tested 
against their ability to promote the degradation of sense strand RNA derived from the 
ORF of the UPRT gene.  The Ui parasite line is able to constitutively express dsRNA 
homologous to the UPRT gene, while the RH parasite lacks this feature.  If active RNAi 
machinery is present in T. gondii, the UPRT dsRNA expressed in the Ui line will be 
converted into siRNAs by a Dicer-like protein resulting in the degradation of the target 
substrate, UPRT ssRNA.  This method of testing for RNAi activity is very advantageous 
because it utilizes lysates obtained from freshly isolated parasites and since the buffer 
used was at physiological pH, it is unlikely that the native protein structures and their 
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interactions are disrupted.  The outcomes of this experiment confirmed the prediction that 
degradation of target UPRT ssRNA would be witnessed only in the lysates obtained from 
the Ui line and not in the RH ones (Figure 3.2).  From this figure, rapid cleavage of the 
substrate is observed, with a rate of 71.8 μM.min-1.mg-1 over the first 15 minutes.  Over 
the course of the experiment, the rate plateaus to 20.9 μM.min-1.mg-1.  Additionally, the 
target RNA was also incubated for the duration of the experiment in assay buffer and 
loading dye to determine if degradation is caused by these two experimental components 
however it was found that the degradation observed is a result of the lysate itself. 
 Since T. gondii is an intracellular parasite that is cultured in human cells, there is 
the possibility of cross contamination between host proteins and parasitic proteins upon 
lysis.  Human cells, like many other mammalian cells have an active RNAi response (Liu 
et al., 2004).   In order to show that the RNAi-like specific degradation of target substrate 
stems from T. gondii lysates alone, comparative analysis between Ui lysates, HFF lysates 
and HFF lysates that were supplemented with UPRT dsRNA was performed.  As 
expected, the dsRNA induced degradation of target substrate was observed only in the Ui 
lysates and the HFF lysates supplemented with UPRT dsRNA, the latter of which showed 
negligible degradation rates by comparison to the parasitic lysates.  HFF lysates that were 
not supplemented with UPRT dsRNA show virtually no degradation in target UPRT 
ssRNA (Figure 3.3).  Kinetically, the observed rate of UPRT ssRNA cleavage for the Ui 
lysates was calculated to be 48.8 μM.min-1.mg-1 with respect to the primed HFF lysates in 
which the observed rate was 16.8 μM.min-1.mg-1. Although the degradation rate of target 
UPRT ssRNA substrate in primed HFF lysates is significantly reduced, it may alter the 
degradation profile slightly if contamination occurs.  To avoid this, parasites should be 
 86
needle passed, therefore preventing cellular debris from being included in subsequent 
lysis steps.   
 
4.2.2 The requirements of dsRNA-directed ribonuclease activity 
 Studies in other organisms showed that the presence of divalent metal ions 
promotes the dsRNA induced target RNA degradation, while the lack of these ions 
prevents target degradation all together.  An experiment was thus designed to test the 
degradation capacity in Ui lysates in the absence or presence of such divalent metal ions.  
Figure 3.4 in the results section displays the behaviour of magnesium dependency for the 
RNAi-like mechanism observed in T. gondii.  It was observed that a lack in magnesium is 
linked to non-degradation of target substrate, while the addition of magnesium sparked 
more aggressive degradation on the target UPRT ssRNA substrate.  From a classical 
RNAi point of view however, this experiment also shows that magnesium dependency is 
most likely linked to the second part of the mechanism in which siRNA directed 
degradation of ssRNA is observed (Figure 3.4).  The observed rate for the cleavage of 
ssRNA in the Ui lysate was calculated to be 20 μM.min-1.mg-1 in comparison to the 33.6 
μM.min-1.mg-1 rate obtained by the addition of divalent metal ions.  The average rate 
obtained for the magnesium enhanced reactions was found to be 49.53 ± 24.29 μM.min-
1.mg-1.  This significant deviation suggests the lack of accuracy in the method used to 
quantify the relative fluorescence units. It is likely that magnesium is also a requirement 
for the production of siRNAs, which in this case occurs in vivo however magnesium 
removal in live parasites was not attempted.  An alternative to this would be the removal 
of divalent metal ions in RH lysates, followed by the addition of dsRNA to induce siRNA 
formation and ssRNA target to assess the degradation profile, if present. 
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 Another key feature of the classical RNAi mechanism was tested through the 
specificity of the RNA target.  The siRNAs that recruit the formation of the RISC 
complex are subsequently cleaved by the slicer enzyme, Argonaute, with the passenger 
strand being expelled, and the guide strand promoting the binding to the mRNA target 
(Preall et al., 2006).  In order to show that the RNAi-like mechanism in T. gondii displays 
the same discrimination between the passenger and guide strands, Ui lysates were 
incubated with UPRT ssRNA as well as UPRT asRNA and their respective degradation 
profiles were visualized.  Figure 3.5 displays the selectivity in degradation between the 
UPRT ssRNA and the UPRT asRNA species.  This result implies that the RNAi 
mechanism in T. gondii resembles the classical mechanism with respect to the antisense 
siRNA or the guide strand incorporation in the degradation complex that may form.   
 
4.2.3 Inducing dsRNA-directed ribonuclease activity in RH lysates 
 Previous observations from the HFF experiment suggest that if the initiator 
dsRNA is present, dsRNA-directed ribonuclease activity is observed.  RH lysates 
generally lack the capability to undergo dsRNA-directed ribonuclease activity towards the 
target ssRNA due to the fact that these lysates lack the dsRNA initiator.  RH lysates were 
thus primed with UPRT dsRNA and tested against the parasite line that does exhibit 
ribonuclease activity, Ui.  As it can be observed from Figure 3.6, both lysates behave 
similarly.  The overall experimental rate averages for the primed RH lysates were 
calculated to be 41.33 ± 8.67 μM.min-1.mg-1, while the Ui rate was 44.09 ± 8.06 μM.min-
1.mg-1.  These averages were obtained by calculating triplicate rates for three different 
experiments.  The variation between the two rates is largely insignificant, suggesting that 
the cleavage of UPRT ssRNA is due to the production of siRNAs from a UPRT dsRNA 
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precursor.  Since the rates are virtually identical, the same set of proteins may participate 
in the dsRNA-directed ribonuclease activity of UPRT ssRNA substrate. 
Since target RNA recognition takes place, we postulated that the inducer molecule 
is also essential.  To show this, RH lysates were pre-treated with HX dsRNA and UPRT 
dsRNA initiators, followed by the addition of HX ssRNA substrate.  The outcome, as 
suggested by Figure 3.7 in the results section, is that specific target degradation takes 
place in a homologous fashion, with HX ssRNA target degradation observed only in the 
reaction initiated with HX dsRNA.  This is a significant result due to the fact that it 
illustrates another key feature of the classical RNAi mechanism described in higher 
eukaryotes.  This feature is the specific degradation of target ssRNA based on the 
homology of the induced dsRNA sequence. 
 To demonstrate this outcome further, HX dsRNA primed RH lysates were tested 
in the presence of UPRT ssRNA as well as UPRT asRNA.  As Figure 3.8 suggests, the 
mismatch between the RNAi inducing specie HX dsRNA lacks homology with both 
substrates, therefore no degradation is detected. 
 
4.3 dsRNA specific ribonuclease activity in T. gondii 
 The hallmark of the classical RNAi mechanism is the production of siRNAs 
which vary in length from 21-23 base pairs in higher eukaryotes to 26 base pairs in plants.  
In terms of evolution, T. gondii has been shown to harbour genes closely related to those 
of plants, especially in the metabolic pathway.  If this holds true to the RNAi pathway 
present in the parasite, the expected length for the siRNAs produced should be closer in 
length to their plant counterparts.  Experimentally, this was successfully shown that a 
accumulation of product within the region of 20-39 base pairs which may be attributed to 
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the Dicer enzyme in T. gondii.  Although a smear is present in Figure 3.9 panel A in the 
results section, it does accumulate in a time dependent fashion reaching the highest level 
after 18 hours.  Similarly, in panel B of the same figure, a intermediate product may be 
observed, suggesting that the lysate does perform cleavage onto the UPRT dsRNA used.  
An accumulation of this intermediate RNA specie is observed in a time dependent 
manner as well, however no accumulation of siRNAs was observed.   To paint a clearer 
picture, a higher percentage polyacrylamide gel may be used to discern between the bands 
present.  Further characterization still needs to be performed in order to determine the 
divalent cation and ATP dependency of the Dicer protein. It should also be assessed 
whether Dicer actively cleaves dsRNA precursors only or if hairpin-RNA undergoes 
degradation in lysates as well. Here it was shown that specific degradation of RNA 
dsRNA takes place through the incubation with RH lysates producing an unmistakable 
degradation product in the expected siRNA size frame.   
 
4.4 Protein expression and purification 
4.4.1 Induction optimization 
 Purified TgAgo in its native form would open the door to a myriad of questions 
and answers.  Generally, a soluble protein retains its native-like structure and 
consequently its function however throughout the induction experiments it was found that 
BL21 induced E. coli produced the protein in inclusion bodies (IBs).  Inclusion bodies 
generally contain proteins that are misfolded and in turn inactive, although some reports 
have indicated that inclusion bodies may harbour some active proteins (Panda, 2003).    
 The parameters that affect the solubility of a protein upon induction are the 
concentration of IPTG inducer, the temperature at which the induction is taking place, the 
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OD of E. coli when induction is started and lastly the time allowed for induction.  
Systematically, these parameters were altered for both the GST and the His tagged 
versions of the recombinant protein.  The inducer concentration was lowered to 5 μM 
IPTG, however upon the separation of the supernatant and insoluble fraction it was 
observed that the protein of interest is still predominantly in the pellet (Figure 3.10).  The 
second parameter that was altered was optical density.  By inducing at earlier bacterial 
growth phases, the accumulation of the recombinant protein is rather slow in culture.  
This is an important feature because it allows for greater soluble protein production 
before triggering the formation of inclusion bodies.  A proposed mechanism of inclusion 
body formation is that cells trigger the formation of IBs upon recognition of toxic cellular 
levels of recombinant protein.  Based on this phenomenon, induction was attempted at 
mid-exponential phase (OD600 = 0.4).  TgAgo ever-expression was successful, however it 
was found in the insoluble fraction.  The soluble induced fraction was almost 
indistinguishable to the uninduced sample that serves as a induction control as observed 
in Figure 3.11.  It was also observed that induction at later phases of bacterial growth was 
accompanied by a reduction in the concentration of recombinant protein.  This is due to 
the accumulation of β-lactamase secreted during bacterial fermentation which accelerates 
the degradation of ampicillin, limiting transformant growth in the culture in the case of 
the HisTgAgo transformants.  In the case of GST-TgAgo the selectable antibiotic was 
kanamycin, and the reduction in protein expression in this case could be attributed to the 
lack of nutrients in the media based on an elevated number of divisions of the E. coli 
cells.   
 The parameter of temperature was also addressed in which E. coli cultures were 
induced at an optical density of 0.4 with minimal concentration of inducer and grown at 
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room temperature and 37°C respectively, for a period of 3 hours.  This approach failed to 
produce an increase in the amount of GST-TgAgo since the uninduced sample closely 
resembles the supernatant profile from the room temperature induced species (Figure 
3.11).  In a last effort to obtain soluble GST-TgAgo, the induction time was increased to 
overnight, while several IPTG concentrations were tested alongside the induction 
temperature.  The results of this experiment are contained in Figure 3.12 in the results 
section.   It was observed that even in this attempt, the recombinant protein was packaged 
into inclusion bodies rendering it potentially inactive. 
 
4.4.2 Solubilization of inclusion bodies and refolding 
Although the presence of a GST tag on a recombinant protein generally increases 
its solubility, in the case of GST-TgAgo it was found to not be effective at producing 
soluble proteins.  For this reason, solubilisation of the inclusion bodies was attempted.  
GST tagged recombinant protein was therefore solubilised with the addition of N-lauroyl 
sarcosine with minimal protein loss in the washing steps, however contaminants were 
present alongside a well defined GST-TgAgo band, as seen in Figure 3.13.  Further 
purification is thus necessary however it was observed that there was no binding between 
the resin and the GST-TgAgo, an outcome of a perhaps misfolded GST tag on the 
recombinant protein.  A GST colorimetric assay was performed and it was determined 
that the GST tag is not active, explaining the lack of binding to the resin. 
Due to the small size of the His tag and the availability of reduced and oxidized 
glutathione for protein refolding, HisTgAgo was used.  It was previously shown that the 
His tagged version of the protein also localizes in inclusion bodies, however through 
protein refolding techniques, it may be rescued.  HisTgAgo was also isolated from 
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inclusion bodies via the same method used in the GST scenario, and refolding was 
attempted.  Confirmation of HisTgAgo isolation was done through mass spectrometry and 
western blot techniques.  Figure 3.14 shows the detection of a His tagged protein by a 
anti-6xHis antibody at the expected molecular weight of 62.5 kDa confirming that the 
protein isolated is recombinant TgAgo.  Moreover, the detection of the His tag does not 
verify that the isolated protein is active. 
 
4.4.3 Argonaute activity 
To determine the activity of the isolated protein, several experiments were 
performed in which the binding capacity was tested.  It was found that through the RNase 
A assay that HisTgAgo cannot protect the full length 735 base pair UPRT ssRNA 
substrate from degradation, however it was able to prevent the degradation of slightly 
smaller fragments as shown in Figure 3.15.  Moreover, by setting Argonaute and the 
substrate alone, it conclusively proved that the purified protein is not responsible for the 
observed degradation (Figure 3.15).  
The experiment that aimed to elucidate whether or not there is any interaction 
between the purified protein and sense strand RNA was the gel mobility shift assay.  The 
results shown in Figure 3.16 show that there is no relative shift between the lanes 
containing ssRNA (lane 2-8) and protein and the lanes containing RNA alone (Lane 1 and 
9).  This finding suggests that perhaps the Argonaute protein isolated from inclusion 
bodies is not active due to severe misfolding.  It is also possible that in order for binding 
to occur an interacting partner is needed.  This may be the case as the Argonaute protein 
in T. gondii lacks a PAZ domain which in other organisms generally facilitates binding to 
target mRNA.  Studies in Drosophila have indicated that the PAZ domain is not a 
 93
requirement for slicing activity, however the study did not address the binding of an 
Argonaute protein lacking a PAZ domain to its substrate RNA (Miyoshi et al., 2005). 
Another possible explanation for the lack of interaction between the Argonaute 
protein and the target RNA is that perhaps a siRNA molecule facilitates the binding 
between the two.  It has been often been reported that the presence of siRNAs promotes 
the formation of the RISC complex, which in turn binds target mRNA (Elbashir et al., 
2001).  Similarly, the Argonaute protein in T. gondii may not act alone, perhaps relying 
on a primitive RISC like complex for the stabilization of target RNA. 
To determine if the Argonaute protein has any interacting partners, an 
immunoprecipitation assay should be performed in which modified siRNAs are incubated 
with fresh Toxoplasma lysates in order to pull down the hypothetical RISC complex in 
this parasite.   
 
4.5 Conclusions 
Through bioinformatic studies, several putative key components of the RNAi 
mechanism of T. gondii have been identified.  These include a PIWI-PAZ domain 
containing protein, several RNase III ribonuclease candidates, a RNA-dependent RNA 
polymerase, a tudor staphylococcal nuclease domain containing protein and several other 
proteins which may serve as transcriptional regulators.  This suggests that T. gondii has 
the necessary components to perform RNA induced gene silencing. 
The ability of T. gondii to amount an RNAi response was tested in vitro.  Through the 
course of the experiments the specificity and requirements of target RNA cleavage 
became clear.  More importantly, it was determined that the introduction of UPRT 
dsRNA causes a time wise degradation in UPRT ssRNA but not UPRT asRNA.  
 94
Moreover, the specificity between the initiator and target RNA was assessed and it was 
found that degradation of the substrate occurs only when the initiator is homologous to 
the target.  It was also recognized that divalent metal ions such as magnesium play a 
crucial role in the RNAi-like mechanism in T. gondii, since removal of magnesium 
prevented the degradation of the substrate RNA. 
A poly-histadine tagged construct of T. gondii Argonaute was used to successfully 
express it and isolate it from the inclusion bodies the BL21 E. coli cells produced.  The 
protein was successfully identified through mass spectrometry as well as western blot 
technique with an antibody that recognizes the poly-histadine tag.  A refolding technique 
was used however this method seems to have been inefficient due to a lack of binding 
between TgAgo and various RNA species under non denaturing conditions.  Furthermore, 
pre-incubated substrate RNA with TgAgo offered no protection from the degradation 
effects of RNAse A towards the full length UPRT ssRNA substrate, showing that the 
interaction between the isolated protein and RNA is limited.  One important find is that 
partial protection was observed, suggesting that the purified protein still maintains some 
RNA binding capacity, although the gel shift assay proved otherwise. 
 New purification methods and induction methods should be performed in order to 
obtain TgAgo in its native form, which would elucidate its role in the RNAi-like 
mechanism of this parasite.  X-ray crystallography of purified native TgAgo would shed 
some light on the organization of the PIWI domain and it would assess the possibility of it 
being the silcer observed in these experiments.  Furthermore, a purified native protein can 
be used in the production of antibodies which may be used in pull down assays to 
determine the interacting partners of TgAgo.  
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APPENDIX A 
 
 
UPRT OPEN READING FRAME 
 
ATGGCGCAGGTCCCAGCGAGCGGAAAGCTCCTTGTCGATCCCCGATATTCGACAAACGACC
AGGAAGAAAGCATTCTCCAGGACATCATCACGAGGTTTCCCAATGTGGTGCTCATGAAGCAG
ACGGCTCAGCTTCGAGCGATGATGACCATCATTCGTGATAAAGAAACACCGAAGGAAGAATT
CGTCTTCTACGCCGACCGCCTGATTCGCCTCCTCATCGAAGAAGCTTTGAACGAACTGCCGT
TCGAAAAGAAGGAAGTGACAACCCCTCTGGATGTGTCATACCATGGAGTTTCCTTTTATTCCA
AGATCTGTGGCGTCTCGATTGTGAGAGCTGGCGAGTCGATGGAAAGTGGCTTGCGGGCAGT
TTGCCGCGGCTGCCGCATCGGGAAAATCCTCATCCAGAGAGACGAAACAACTGCGGAGCCT
AAGCTGATCTACGAGAAGCTGCCTGCCGACATTAGAGATCGCTGGGTGATGCTGCTCGATC
CGATGTGCGCGACGGCGGGCAGTGTGTGCAAAGCGATCGAGGTCCTCCTGAGGCTCGGCG
TGAAGGAAGAGAGAATCATTTTCGTCAACATTTTGGCTGCTCCCCAAGGCATTGAACGTGTTT
TCAAGGAATACCCGAAAGTCCGCATGGTCACTGCTGCTGTTGACATCTGCCTGAACTCGAGG
TACTACATCGTCCCCGGCATTGGTGATTTCGGTGACCGGTACTTTGGAACCATGTAG 
 
HXGPRT OPEN READING FRAME 
 
ATGGCGTCCAAACCCATTGAAGACTACGGCAAGGGCAAGGGCCGTATTGAGCCCATGTATA
TCCCCGACAACACCTTCTACAACGCTGATGACTTTCTTGTGCCCCCCCACTGCAAGCCCTAC
ATTGACAAAATCCTCCTCCCTGGTGGATTGGTCAAGGACAGAGTTGAGAAGTTGGCGTATGA
CATCCACAGAACTTACTTCGGCGAGGAGTTGCACATCATTTGCATCCTGAAAGGCTCTCGCG
GCTTCTTCAACCTTCTGATCGACTACCTTGCCACCATACAGAAGTACAGTGGTCGTGAGTCC
AGCGTGCCCCCCTTCTTCGAGCACTATGTCCGCCTGAAGTCCTACCAGAACGACAACAGCA
CAGGCCAGCTCACCGTCTTGAGCGACGACTTGTCAATCTTTCGCGACAAGCACGTTCTGATT
GTTGAGGACATCGTCGACACCGGTTTCACCCTCACCGAGTTCGGTGAGCGCCTGAAAGCCG
TCGGTCCCAAGTCGATGAGAATCGCCACCCTCGTCGAGAAGCGCACAGATCGCTCCAACAG
CTTGAAGGGCGACTTCGTCGGCTTCAGCATTGAAGACGTCTGGATCGTTGGTTGCTGCTACG
ACTTCAACGAGATGTTCCGCGACTTCGACCACGTCGCCGTCCTGAGCGACGCCGCTCGCAA
AAAGTTCGAGAAG 
 
 
 
 
 
 
 
 
Figure A1 UPRT and HXGPRT open reading frames - Plasmids carrying the ORF for 
HXGPRT and UPRT respectively were used with the appropriate primer pairs in order to 
obtain the desired PCR product.  The PCR products were purified and used for generation 
of RNA species as described in the Materials and Methods section. 
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APPENDIX B 
 
pET28bHisAgoORF PLASMID  
 
 
 
 
 
 
 
 
 
 
 
 
 
TgAgo OPEN READING FRAME 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATA
TGGCTAGCATGACTGGTGGACAGCAAATGGGTCGGGATCCGAATTCGATGATCATGCCTCC
CCGAAATCGCGTGGCGAAGACAGAGCAGCTGTTAAGCCTCGTCTTCGGGCCACAGGGACAT
TCAGCCCCGAAGGTTCTCGATGCTTTTGGTGTAATATTGCAGCTTGAAGCAAAAACAGCACA
GGGGAGGGTCCTGGAATCCCCTCTTATCAAATACCGCGAAGTACCAGGCGGAGGCCCTGGC
AGGTCGTCGAAAACAGTTCGACCAGCTCAGGGCGACTGGAATTTGCGGGACGCGGCTTTCT
GTCGTGGCACAGTATGCAAAGTCTGGGCATTGTATTCTTTCGTTGAGACGAGCCAAAATGTT
ATTGAGAACTTGGCAAGAGTCCTGAAGACGCAAGGCGCAAAATACGGCGTGAATTTGACCA
CTAAACCCGGACTGGGAGCTTACACGAGAAACGATCGGCGCCCCATGCTTGACCAGTTCGC
CGCCTTTGTTGCACTCGCAAAAACCAAAGGGTGCGAACTCCTCTTCGTGATTTTGAACGAAC
GGGTCTCCCTGGACATCTACCAAATTGTGAAGTCTTGCACGGACGTAAACTTCCCGTCACAG
TGTTTAAACGGAAGACACAAATGTATCGACGCCATCTTCCGTGGAGACAATCCAAACCCGCA
GTATTTCGCAAATGTTATGTCCAAAGTCAACATGAAGTTGCAAGGAGTGAATCAAACCCTCGA
GGCGGATATAATAAAGCAAGAAATCGGAACGGACAAGAGCACATTGGTCTTGGCGGTAGAA
ACATCATTCTTTGCAAATCCGACTAAAACTTCTCCCCCGCCGACAGCGCCCATTGTGTGTGC
GTGTACGGGAAACATGGACGATGATCTTGGCGCGTTCGGTCATGCTGTTTGCGTTGAATCGC
GAAAGCATCCCATAGTGACTGATATTGGGAGTATGTTTAAAACTATTCTCTCCTATCGAAAGA
CAACGAAAAACTGGCCGGCGCGAATCATCTACCTTCGATCTGCCACTACAGAAGCACACTTC
CCTCTTGTATTGGCCGGCGAAATCCGTGCGATCGAAGAATTATATGTTCGTGAAAACCGTTC
AAAACCTCGAATCCTCGCCGTAGCAGTGCAAAGGCGACAGCAAACACGTTTATTCCCTACGA
AGGAGATGCAGGCTCAGGGAAACAATCTGCCACCAGGGTTCTTGCTTGCGAATAGTCTGCA
ACATCCAGGGCACTTCCGAAATTTCTTGTTGATCTCACACAAAGCACTCCAGGGAACAGCGC
GCCCAACAAGGTATTACATTTTAAGAGACGATGCGAACCGCGACATGGAAAAAGTTGCCCAG
CTGATGTACTCTCTGTGCCATGTGTACGGTCGCTGCCAGCGAGCGGTCTCCATTCCCGCTC
CCCTGTACTACGCCGAGCTGCTGGCGGCAAGAGCTCAAAGCTACATGAAGGTTGGCATGCG
TAGAGAAAGAAATATAGATATTGACGATCTTTCTCACCTCAGTGGCGAAGCTGGGGAAAAGA
TGCTGACTGAGACCCGACATTTTGCCGATGAGTATTTGAGAAGCACGGCAGCTAAGGTGACC
CCGATGGTGTTCTGTTGAGACAGCATTGATAGTATTTTTGCAGGTGTGTCGTAATATTCCAAG
CTGCATACTATGACTCAGCGAAGCAGCCCAGGATTCTCCTGCTCCATGACCCCCAAGCTTGC
GGCCGCACTCGAG 
 
 
Figure B1 T. gondii Argonaute open reading frame 
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APPENDIX C 
 
MASS SPECTROMETRY EVIDENCE FOR ARGONAUTE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C1 Mass Spectrometry evidence of TgAgo isolation 
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APPENDIX D 
 
 
QUANTIFICATION OF ISOLATED HisTgAgo 
Bradford assays were read at 595 nm using a UV-Vis Spectrophotometer.  A standard 
curve was created using known concentrations of Bovine Serum Albumin (BSA).  The 
standard curve is depicted below. 
 
Sample Absorbance @ 595 nm Concentration (μg/mL)
BSA 0 0
BSA 0.049 1
BSA 0.101 2
BSA 0.239 4
BSA 0.355 6
BSA 0.482 8
BSA 0.596 10
HisTgAgo 0.057 0.4325 μg/μL  
 
y = 0.0607x - 0.0087
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Figure D1 Quantification of isolated protein through Bradford assay 
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